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ABSTRACT 
Leptospira borgpetersenii serovar hardjo isolates, (n=200), were examined by 
hybridization for restriction fragment length polymorphisms (RFLPs) in sphA and sphB. 
These genes, sphA and sphB, were previously cloned from L. borgpetersenii serovar hardjo 
(strain Sponselee) and encode a sphingomyelinase gene and a sphingomyelinase-related gene, 
respectively. A single RFLP was noted in sphA, while nine were detected in sphB. The 
RFLP detected in sphA was found in a single isolate and may be due to introduction of an 
insertion element. RFLPs detected in sphB were found in a region of tandem repeats within 
the open reading frame. Differing numbers of repeats of a 45 bp sequence were found in 
some isolates of serovar hardjo, while other isolates had a single copy of the 45 bp sequence 
followed by differing numbers of repeats of a 30 bp sequence. The sequence of the 30 bp 
element suggested deletion of 15 bp from the 45 bp sequence. Tests using reverse 
transcriptase-PCR showed that sphA and sphB were transcribed during growth of serovar 
hardjo in culture. Polyclonal antisera prepared against recombinant SphA and SphB reacted 
with a Triton X-114 outer membrane extract of serovar hardjo (strain Sponselee), which 
indicated that both sphA and sphB are transcribed, translated, and transported to the 
periplasmic space or outer membrane. Hamsters were immunized with recombinant SphA 
and SphB and challenged with a highly virulent isolate of serovar hardjo (strain 197). 
Hamsters were not protected from infection or disease when immunized with either SphA. 
SphB, or both. 
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CHAPTER 1: GENERAL INTRODUCTION 
Leptospirosis is one of the most common zoonotic infections worldwide and occurs in 
virtually all mammals. It also is an important disease of food animals and results from 
infection with one of the many pathogenic serovars of Leptospira. Leptospires invade the 
host after being deposited on mucous membranes. After a variable incubation period of four 
to twenty days, leptospires circulate in the blood and replicate in many tissues. In some 
cases, the period of leptospiremia is associated with development of acute clinical signs such 
as fever, jaundice, hemoglobinuria, and renal failure. Appearance of circulating antibodies 
coincides with clearance of leptospires from the blood and resolution of the acute clinical 
signs. However, leptospires may persist in the kidneys and reproductive tract and may be 
shed in urine of infected animals for months after infection. Persistently infected animals 
may go undetected until effects on reproduction become apparent and are an important 
reservoir of infection for other animals and people. 
Factors associated with virulence in Leptospira have not been clearly defined. Several 
factors, including lipopolysaccharide (LPS), motility, cytoto.xin(s), and hemolysin(s) have 
been suggested to be important for virulence. Hemolysin activity among some of the 
pathogenic Leptospira is attributed to sphingomyelinase activity. A gene encoding 
hemolysin and sphingomyelinase activity, sphA, and a related gene, sphB, have been cloned 
from Leptospira borgpetersenii serovar hardjo (strain Sponselee). Virulence factors may 
provide targets for protective host immune responses and could be useftil in the formulation 
of effective vaccines. 
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Current leptospiral vaccines stimulate host immune responses. The humoral response 
induced in the host includes antibodies directed towards leptospiral LPS. The cell-mediated 
immune response induced has not been well characterized. Efficacy studies involving these 
vaccines, as well as passive immunization studies using monoclonal antibodies against LPS, 
show that antibodies against LPS are sufficient for protection against some types of 
leptospirosis. In contrast, efficacy studies of vaccines for protection of cattle from infection 
with L. borgpetersenii serovar hardjo have shown that the presence of anti-LPS antibodies 
does not protect cattle from infection or disease by this organism. 
Leptospira borgpetersenii serovar hardjo is the most common cause of leptospirosis in 
cattle worldwide. Cattle can become persistently infected with this serovar and serve as the 
major reservoir of this infection in the environment. The infection can spread 
transplacentally from dam to young, by contact with infected urine or tissues, by venereal 
transmission, or by contact with contaminated soil or water. Infection can result in flaccid 
mastitis, acute milk-drop syndrome, abortion, stillbirth, and the birth of weak neonates, but 
the clinical signs associated with serovar hardjo infection vary in different regions of the 
world. 
Isolates of L. borgpetersenii serovar hardjo have been shown to vary genetically by 
restriction endonuclease analysis, random amplified polymorphic DNA analysis, and with 
respect to the number and location of an insertion sequence element. The purposes of the 
studies described in this thesis were to detect and characterize variations present in the sphA 
and sphB genes of isolates of Z,. borgpetersenii serovar hardjo, to determine if these genes are 
expressed in serovar hardjo cells growing in culture, and to evaluate the immimogenicity of 
the proteins SphA and SphB in a hamster model of serovar hardjo infection. 
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Dissertation Organization 
The thesis is organized to include two chapters containing manuscripts prepared for 
publication, which follow the General Introduction and Literature Review. The first 
manuscript is entitled, "Evaluation of genetic variability in, and expression of, sphA and sphB 
in Leptospira borgpetersenii serovar hardjo." The experimental data of this manuscript detail 
differences detected at the genetic level among sphA and sphB of over 200 different L. 
borgpetersenii serovar hardjo isolates and examines expression of these genes by reverse 
transcriptase-PCR and immunoblotting. The second manuscript is entitled, "Evaluation of 
recombinant protein vaccines containing portions of SphA and SphB in a hamster model of 
L. borgpetersenii serovar hardjo infection." This manuscript provides information on the use 
of recombinant sphingomyelinase proteins as vaccines in a hamster challenge model. A 
general discussion and references follow the second manuscript. Appendix A contains 
figures and .A.ppendix B contains experimental details that may aid in interpretation of the 
data. 
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CHAPTER 2: LITERATURE REVIEW 
General Description 
Leptospira are obligate aerobic bacteria that are members of the family Leptospiraceae 
order Spirochaetales. The bacterial cell is helical in shape, motile, and flexible. Size is 
variable from 3 to 20 fj.m in length with a diameter of 0.1 to 0.15 um. Both pathogenic and 
saprophytic Leptospira have been described. Pathogens can infect and produce disease while 
saprophytes exist in the environment and do not cause disease. Further classification has 
been based on antigenic relatedness. This serologically based system describes over 200 
pathogenic serovars distributed among 23 serogroups in Leptospira interrogans. Saprophytic 
Leptospira biflexa is comprised of 38 serogroups with 65 serovars (95). 
Classification 
A system of genetic classification is currently used that places the pathogenic 
Leptospira into one of seven species: L. interrogans (sensu stricto), L. nogiichii, L. inadai. L. 
weilli, L. kirschneri, L. santarosai, ox L. borgpetersenii (119, 159); saprophytic isolates are 
organized into four species: L. biflexa (sensu stricto), L. meyeri, L. wolbachii. or L. parva 
(77). A second genus of saprophytes, Leptonema illini, also is placed within the 
Leptospiraceae family (119). Ramadass et ai, however, separates L. biflexa into six DNA 
relatedness groups and suggests use of the name L. biflexa be limited to members of serovars 
patoc, andaman, and bessemans (120). 
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Pathogenesis of Leptospirosis 
Leptospirosis is a worldwide zoonosis and an important disease of livestock. Infection 
with one of the many pathogenic serovars oiLeptospira can result in disease. Initially, 
leptospires invade the host after coming in contact with mucous membranes. After a variable 
incubation period (four to twenty days) (19), leptospires circulate in the blood and replicate 
in multiple tissues including the liver (12), kidney (12, 40,41. 53), lung (107), genital tract 
(39-41, 53), and central nervous system (104, 110). During this period of leptospiremia, 
acute illness can occur and clinical signs may include fever, jaimdice, hemoglobinuria, renal 
failure, and pulmonary hemorrhage. In some cases, infection can be fatal. Once circulating 
antibodies appear, clearance of leptospires from the blood occurs, and acute clinical signs 
may resolve. Leptospires can persist in tissues throughout the body, in spite of clearance 
from the blood. 
Sites of persistence within the body are often immunoprivileged areas and can include: 
the central nervous system (110), cerebrospinal fluid (104), kidney (12, 40, 41, 53), aqueous 
humor (104). and both male and female genital tracts (39-41. 53). Persistently infected 
livestock may shed leptospires into the environment for months after infection (97, 142), 
providing an important reservoir of infection for other animals and man. These animals may 
go undetected clinically until the effects on reproduction become apparent. 
Prevalence and Clinical Signs of Leptospirosis in Cattle 
Estimates of the prevalence of bovine leptospirosis vary by the geographic region 
surveyed and the methods used to estimate the infection rate. Because of the difficulty in 
isolation of leptospires from infected animals, infection rates are usually estimated by 
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conducting surveys to detect serologic reactivity. Serologic evidence gathered in the United 
States and Puerto Rico indicated that 49% of the bovine sera examined contained antibodies 
at a titer of s 1:100 by the microscopic agglutination test to I or more of 12 leptospiral 
serovars tested (106). Antibodies were most frequently detected to serovar hardjo (29%), 
serovar pomona (23%), serovar icterohaemorrhagiae (20%), and serovar canicola (11%) in 
the sampled population. Studies of this kind tend to overestimate the prevalence of infection 
because of the widespread use of leptospiral vaccines in North America. Studies based on 
isolation of leptospires from the tissue of cattle at slaughter have generally indicated a 
prevalence of 2 to 15% (54, 106). Isolates obtained in these studies were most frequently 
serovar hardjo, and less commonly serovars pomona and grippotyphosa. 
In Chile, 44.9% of healthy cattle had significant antibody titers to Leptospira with the 
most common reactions to serovars hardjo and pomona (160). A study in Canada 
determined herd seroprevalence with antibody titers > I ;80 considered positive (118). Results 
from this study indicated 39% of herds tested showed reactivity with one or more serovars of 
Leptospira. Herd seroprevalence for individual serovars was 26% for pomona. 14% for 
hardjo, 10% for icterohaemorrhagiae, and 2% for grippotyphosa. While the prevalence 
estimates vary in these and other studies, it is clear that serovar hardjo is the most frequent 
cause of leptospirosis in cattle with serovar pomona the second most common. 
Acute clinical signs can occur in cattle infected with various serovars oiLeptospira. 
most commonly with serovar pomona. Severe clinical signs are most common in calves and 
feeder cattle and may include high fever, hemolytic anaemia, hemoglobinuria, jaundice, and 
occasionally death. In some cases, lesions detected in the kidneys at slaughter are the only 
indications of infection in the herd (138). When cattle are infected with serovar pomona and 
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other virulent serovars during pregnancy, abortions can occur. In lactating cows, acute 
leptospirosis may result in agalactia with small quantities of blood-tinged milk (51). 
A particular clinical syndrome occurs in lactating cattle with leptospirosis, most 
commonly caused by serovar hardjo. This syndrome is called "milk-drop syndrome" and 
presents as a transient fever with a significant drop in milk production (II5, 137). The udder 
is soft and flabby and milk that is produced is yellow, contains clots, and has a high somatic 
cell count. Lactating cattle usually recover within ten days, but lactation may be depressed 
for the rest of the lactation period. Subclinical forms of decreased milk production also are 
described in herds infected with serovar hardjo and this may result in significant loss of 
revenue (35, 74). 
Persistent leptospirosis is almost exclusively the result of infection with serovar hardjo 
and, to a lesser extent, serovar pomona. It is associated with reproductive failure, fetal 
infection, abortion, stillbirth, or birth of premature and weak, infected calves (20, 42. 50, 63, 
75, 94, 142). Infected, but apparently healthy calves, also may be bom (20) and serve as 
reservoirs of infection. The abortions or other reproductive signs may occur weeks to months 
after the initial infection of the pregnant animal. 
Serovar Hardjo 
Serovar hardjo is a genetically diverse group of organisms and contains isolates that 
belong to two different species of Leptospira: L interrogans serovar hardjo type 
hardjoprajitno (155) and L. borgpetersenii serovar hardjo type hardjo-bovis (119). These 
organisms are serologically indistinguishable, but genetically quite distinct (55, 103, 145). 
The two types of serovar hardjo can be distinguished firom one another by restriction 
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endonuclease analysis (REA) of DNA (55, 103, 145). The distribution of infection with 
these two species of serovar hardjo is quite different. Throughout the world, serovar hardjo 
type hardjo-bovis is the most common cause of bovine leptospirosis (54, 141, 154). 
Restriction endonuclease analysis (122,143-145) demonstrated that all serovar hardjo 
isolates from the United States, Canada, and New Zealand were type hardjo-bovis. In 
contrast, serovar hardjo type hardjoprajimo has only been identified in the United Kingdom, 
a few places in Afiica, and Mexico. There is only a single report of serovar hardjo type 
hardjoprajimo isolated in the United States, and this was from a horse in California (92). In 
the United Kingdom, over half of the serovar hardjo isolates examined in several studies (55, 
103) were identified as serovar hardjo type hardjoprajitno. There is evidence that serovar 
hardjo type hardjoprajimo isolates may be more pathogenic for cattle than type hardjo-bovis 
isolates (55) 
Variability also has been demonstrated within type hardjo-bovis isolates using REA 
(143) resulting in classification of the isolates as REA types A or B. Type A isolates of 
hardjo-bovis are common throughout the world, but type B isolates are less common and 
most of the type B isolates are from the United States (166). In a survey of isolates collected 
within the United States and Puerto Rico, 85% of isolates were identified as type A and 15% 
of isolates as type B (106). 
Genetic variability also was demonstrated among hardjo-bovis isolates by hybridization 
with an insertion element (166). The differences were consistent with the geographic regions 
from which the strains were isolated, suggesting the existence of several different clonal 
populations of type hardjo-bovis. Other techniques including random amplified polymorphic 
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DNA fingerprinting (30, 62) and arbitrarily primed PCR (116) also show genetic 
heterogeneity among hardjo-bovis isolates. 
Cattle are considered to be a maintenance host for both species of serovar hardjo (46), 
and the bovine immune response to infection with these organisms is often minimal. 
Agglutinating antibody titers may be low to undetectable, even in animals from which the 
organism is isolated (46, 142, 160). Infection usually leads to localization of the infecting 
organism to the kidney with development of persistent renal shedding of leptospires (113). 
In experimentally infected cattle, shedding of leptospires in urine has been shown to persist 
for over 18 months (142), and may be lifelong in naturally acquired infections. In addition, 
serovar hardjo can be isolated from the pregnant uterus (45) and persists in the tissues of the 
male (39) and female genital tracts (45, 47). These sites of infection raise the possibility of 
venereal transmission (44) in addition to transmission by contact with infectious urine. 
Organisms also have been demonstrated in vaginal discharges following abortion and calving 
(47) providing another means for transmission of the organism to susceptible hosts. 
Further evidence of the involvement of serovar hardjo in disease in cattle included 
serological evidence of infection in cattle experiencing abortions and isolations from herds 
demonstrating clinical signs of abortion (36, 71, 75, 121, 139). In addition, serovar hardjo 
was isolated from aborted bovine fetuses (42,48, 50,72), from a viable premature calf (63), 
and from herds showing drops in milk production (42, 71, 75, 121). 
Early attempts to reproduce infection with serovar hardjo resulted in seroconversion 
and, in some cases, a febrile response (134-136). In other studies, inoculation with serovar 
hardjo by the intracervical route produced pathological changes and abortions (70) and 
intraplacentomal inoculation resulted in abortions, mummification, stillbirth, and the birth of 
10 
weak calves (47,49). Studies using intramuscular (43), intravenous (142), and conjunctival 
routes of exposure to serovar hardjo (20) also produced abortion (20,43, 142), stillbirth (20). 
birth of weak calves (20,43, 142), and mastitis (142). 
Infection of cattle with serovar hardjo type hardjo-bovis in the United States can result 
in abortion, stillbirths, and the birth of weak neonates. Subclinical mastitis and decreased 
milk production also may occur (74). Human infections, while they may occur, are not 
commonly reported. However, in other parts of the world, the spectrum of disease produced 
by type hardjo-bovis infection varies. 
In the British Isles, disease in both cattle and man is common and may be caused by 
either type hardjo-bovis or type hardjoprajimo (66). Throughout Europe, clinical infections 
with type hardjo-bovis occur in cattle while most human infections are found in The 
Netherlands (66). In Portugal, there is seemingly little disease in cattle, but a high degree of 
seropositivity is seen (29). Disease in man is seen in Australia and New Zealand (100) while 
the disease is not clinically apparent in cattle (23, 38, 131). Experimental infection of cattle 
using hardjo-bovis isolates from several parts of the world has shown differences in shedding 
pattern, tissue localization, histopathological lesions, and host humoral response (17). While 
management practices may play a role in the differences seen in clinical presentation, the 
observed differences in biological behavior also may reflect variability among type hardjo-
bovis isolates with respect to virulence and host adaptation. 
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Virulence Determinants and Immunity' 
To date, no work has demonstrated specific virulence attributes within Leptospira, 
although several have been suggested including leptospiral lipopolysaccharide (LPS), 
motility, cytotoxin(s), and hemolysin(s). 
Lipopolysaccharide. Pathogenic Leptospira are resistant to complement-mediated 
killing (86); this resistance is thought to be mediated by the LPS (81). Alterations in LPS 
have been implicated in evasion of host-response (18, 20). Leptospiral LPS is 
morphologically and chemically similar to that from other Gram-negative bacteria (150) and 
is active in the limulus lysate gelation test (27, 33), stimulates B cells in mice (80, 129), and 
induces monocyte activation (27). Leptospiral LPS, however, has weaker endotoxic 
properties compared to other Gram-negative bacterial LPS as measured by pyrogenicity in 
rabbits (27,33), lethal toxicity in mice (27, 129), and toxicity in chicken embryos (33). 
Leptospiral LPS also fails to induce the local Shwartzman reaction in rabbits (27, 33). 
Motilitv'. Motility of leptospires may play an important role in virulence. The 
characteristic corkscrew motion and helical shape of the organism allow effective movement 
through viscous environments (89, 91). Motility is likely critical for penetration of mucus 
membranes and spread throughout tissue once infection has occurred. 
C}totoxin(s). Cytopathic effects on certain cell cultures have been attributed to a 
leptospiral cytotoxic factor (108, 109). TTie cytotoxic activity has not been characterized, and 
it is unclear if it is limited solely to virulent organisms. Several studies have shown 
differences in cytotoxic activity between virulent and avirulent strains of the same serovar 
(157) and between virulent and avimlent serovars, including saprophj^es. These studies 
found that virulent strains and serovars possessed cytopathic activity, while avirulent or 
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saprophytic isolates either did not possess cytopathic activity or that activity was less than 
that of virulent organisms (26, 108). Others, however, have reported cytopathic acti\ity in 
association with both virulent and saprophytic leptospires (58, 149, 151). 
Hemolysm(s). Some saprophytic and pathogenic serovars of Leptospira demonstrate 
hemolytic activity. This activity is attributed to phospholipase A in the saprophytes; some 
pathogens demonstrate both sphingomyelinase and phospholipase A activity (90, 158). 
Genes encoding hemolytic activity have been cloned from Leptospira (32, 34, 60, 152). The 
gene, sphA, cloned by del Real et aL (34) from type hardjo-bovis encodes both hemolytic and 
sphingomyelinase C activity. Further analysis using this gene in hybridization studies 
demonstrated significant cross hybridization with L. interrogans, L. borgpetersenii, L, weilli, 
L. santarosai, L. alstoni, and L. nogitchi (126). These studies led to the discovery of an 
additional related gene in type hardjo-bovis (127) and four other related genes in L. 
interrogans serovar copenhageni (strain Wijnberg). Gaastra et al. suggested the existence of 
a gene family of sphingomyelinase genes which can be divided into two groups—one group 
found in L. interrogans, L. nogiichi, and L. alstoni', the second group found in L. 
borgpetersenii, L. weilli, and L. santarosai (61). Of the pathogenic species tested, only L. 
inadai does not contain regions that hybridize with sphA, while among saprophytes, only a 
single isolate of L. meyeri demonstrates hybridization with this gene (126-128). 
Immunity. The humoral immune response to Leptospira is considered to be important 
for protection (1,3), especially the development of agglutinating antibodies (2). The role of 
cell mediated immunity in protection from leptospiral infection has not been thoroughly 
investigated. Antibodies produced against LPS and the polysaccharide component of LPS 
have protected hamsters from fatal leptospirosis (88). In addition, a monoclonal antibody 
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(MAb) to a determinant on LPS has protected against infection by passive transfer in 
hamsters (89). Immunization with an outer envelope preparation was shown to provide 
protection against infection in guinea pigs and dogs, similar to that provided by 
immunization with whole cells (14, 15, 140). 
In cattle, whole-cell bacterins (78, 99, 147) and a cell wall subunit vaccine (147) have 
demonstrated protection against infection with various serovars of Leptospira. When 
infection did occur in vaccinated cattle, urinary shedding of leptospires was of shorter 
duration than that seen in non-vaccinates (99). More recent studies evaluating the efficacy of 
whole-cell vaccines for protection of cattle from serovar hardjo infection have not been 
consistent with these previous findings. In studies using pentavalent killed, whole-cell 
vaccines containing type hardjoprajitno (20) and type hardjo-bovis (21), vaccinated cattle 
were not protected from infection with type hardjo-bovis or development of leptospiruria. In 
addition, transfer of the infection to the fetus was noted (20). An additional study performed 
using a killed monovalent type hardjo-bovis vaccine demonstrated that while vaccination 
induced development of IgG and agglutinating antibodies to LPS, it failed to protect against 
infection with type hardjo-bovis (18). 
Differences in vaccine efficacy between protection from acute disease and protection 
from persistent infection may be due to differences in the immune response necessary for 
protection in each of these cases. Clearance of Leptospira in an acute infection may rely on 
the presence of agglutinating antibodies while clearance of Leptospira from sites of 
persistence may require other elements of the immune response, such as the development of 
urinary antibody (97). However, the antibodies induced by vaccination with whole-cell 
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products tested may have been of inappropriate specificity or isotype, or the immunogens of 
type hardjo-bovis may have been unavailable to the host (18). 
Direct comparison of the cattle vaccine efficacy experiments is difficult. Differences in 
experimental design, vaccine formulations, challenge organism, route of challenge, and 
effectiveness of challenge all will influence the experimental results. In addition, 
improvements in cultural and diagnostic techniques are likely to have enhanced sensitivity in 
detection of vaccine failures. 
Hemolysins and Sphingomyeiinases 
Genes sphA and sphB in type hardjo-bovis. Sphingomyelinase activity has been 
demonstrated with thin-layer chromatography (128) using L. borgpetersenii serovar hardjo 
(strain Sponselee), a Dutch field isolate of type hardjo-bovis. This activity was associated 
with the cell pellet, as opposed to the enzymatic activity seen with L. interrogans serovar 
pomona (strain Pomona) and L. interrogans serovar canicola (strain Hond Utrecht IV) which 
was secreted into the culture supernatant. Other studies using isolates of type hardjo-bovis 
fi-om New Zealand (73, 76) and the United States (5) failed to demonstrate hemolytic 
activity. 
A chromosomal firagment cloned fi-om strain Sponselee demonstrated both hemolytic 
and sphingomyelinase activity when expressed in Escherichia coli (34). Characterization of 
the cloned DNA fi:agment revealed an open reading fi^ame (ORP), designated sphA. This 
ORP contains regions of homology at the nucleotide and amino acid level to a pair of 
bacterial sphingomyelinases, the Staphylococcus aureus beta-toxin, and an enzyme fi-om 
three Bacillus cereiis strains (128). The protein encoded by this ORF is predicted to have a 
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molecular mass of 63,268 Da, however, the full-sized translation product could not be 
detected in E. coli minicell preparations. A 39.2 kDa product was detected and was thought 
to be the product of the sphA gene following posttranslational processing within E. coli. 
A second region of serovar hardjo (strain Sponselee) DNA that hybridized with sphA 
was described. This region contains a partial OEIF showing homology with sphA and the S. 
aureus and B. ceretis enzymes. However, the cloned fiagment did not include the entire ORP 
and did not show enzymatic activity when cloned into E. coli. Segers et al. described this 
ORF as a putative sphingomyelinase and designated it sphB (126, 127). Because of the lack 
of genetic transformation systems in Leptospira, experiments to delete or mutate these genes 
and then determine effects on virulence have not been possible. 
Phospholipases as virulence determinants in other organisms. Phospholipases are 
possessed by many bacteria and are categorized as phospholipase A, C. or D (PLA, PLC, or 
PLD), depending on the site of enzymatic action within the phospholipid (Fig. 2.1). Certain 
phospholipases will only act on a single substrate, while others are able to act on several 
different phospholipids. Bacterial phospholipases clearly play a role in the virulence of some 
organisms, while in other bacteria this role is not clear. Several examples of the role of 
bacterial phospholipases are described in the following paragraphs (as reviewed by (133)). 
Mutations in the Clostridium perfringens a-toxin, a PLC, decreased virulence in a 
mouse myonecrosis model (11). The toxin also plays a role in cases of enteritis or 
enterotoxemia in domestic animals caused by this organism. Damage to the circulatory 
system seen with infection can include intravascular hemolysis, capillary damage, and 
platelet aggregation. These findings are consistent with the presence of a circulating 
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Figure 2.1: Sites of phospholipid hydrolysis by phospholipases A-, (PLA,), C fPLC), and 
D (PLD). Sphingomyelin is shown as an exemplary molecule, but the 
cleavage site relative to the phosphate moiety is the same in other 
phospholipids, such as phosphatidylcholine, phosphatidylserine, 
phosphatidylehthanolamine, and phosphatidylinositol. Removal of a fatty 
acid tail by the action of FLA, converts phospholipids to the lyso-form, which 
is the preferred substrate of some phospholipases. The figure and legend were 
reproduced from J. G. Songer (133). 
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hemolytic toxin. Signs similar to those naturally produced through infection can be induced 
through administration of toxin preparations, and immunization with a toxoid is protective. 
In Listeria monocytogenes, an intracellular pathogen, a pair of phospholipases with 
overlapping functions have been described. These phospholipases, PLC-A and PLC-B, may 
interact with each other and with listeriolysin-0, a thiol-activated toxin, to enhance escape 
from the phagosome and result in optimal intracellular growth (132). 
Pseiidomonas aeruginosa also possesses two distinct phospholipases, PLC-H and PLC-
N, encoded by plcS and plcN, respectively. Both hydrolyze phosphatidylcholine while PLC-
H also can act as a sphingomyelinase. Mutations in plcR, a locus involved in regulation of 
plcS, resulted in increased PLC production and hemolytic activity. However, virulence 
compared to wild type was decreased. Other studies with AplcS-AplcR mutants 
demonstrated an even greater decrease in virulence suggesting PLC-H may play a role in 
pathogenesis of infection (114). 
Sequences resembling plcN and plcS of P. aeruginosa have been identified in 
Mycobacterium tuberculosis (85). The identified genes, mpcA and mpcB, when cloned into 
Mycobacterium smegmatis, were able to express PLC activity. Sphingomyelinase, PLC, and 
PLD activities were found in cellular extracts of several species of mycobacteria including: 
M. tuberculosis, M. bovis, and M. marinarum while M. bovis bacille Calmette-Guerin (BCG) 
possessed only PLD and sphingomyelinase activity. Hybridization studies using mpcA and 
mpcB revealed reactivity with DNA fi"om M. tuberculosis, M. bovis, M. bovis (BCG), and M. 
marinarum, but no reaction with either M. avium or M. intracellulare. 
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A pair of sphingomyelinases have also been described for Helicobacter pylori. One of 
these sphingomyelinases appears to be membrane bound and cross-reacts with antiserum 
produced against a sphingomyelinase from B. cereiis (98). 
Sphingomyelinase. Sphingomyelinases fimction in the degradation of sphingomyelin. 
Sphingomyelin is found as a constituent of biological membranes in eukaryotic organisms 
and is formed through the addition of a phosphocholine moiety from phosphatidylcholine to a 
ceramide backbone. 
A sphingomyelinase signaling pathway has been characterized. In this pathway, 
sphingomyelinase acts on sphingomyelin to produce ceramide. Ceramide is involved in the 
sphingomyelin signaling pathway. Ceramide mediates tiunor necrosis factor-a (TNF-a) and 
interleukin 1-p action (96). Ceramide also suppresses cellular growth and induces apoptosis 
(69). It is not clear whether bacterial sphingomyelinases can act to induce apoptosis in vivo 
(8, 69), but bacterial sphingomyelinases can induce apoptosis in vitro (82-84). 
Variabilit}' and expression of sphA and sphB and their potential as vaccines. 
\V'hether 5/7/J.4 and or sphB are expressed in type hardjo-bovis is unknown. The exact 
functions of the proteins encoded also are unknown. It has been suggested that 
sphingomyelinases play a role in obtaining free fatty acids or iron, both of which are 
necessary for leptospiral growth. Through their action on sphingomyelin and resulting 
production of ceramide, it has been suggested that these products may play a role in 
host/organism interaction through the sphingomyelin signaling pathway. 
The genetic variability of hardjo-bovis isolates, differences in phenotypic expression of 
hemolytic activity, and the variability seen in clinical presentation of serovar hardjo 
infections have led us to investigate multiple isolates of serovar hardjo for differences in, and 
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expression of, sphA and sphB. The potential role of sphingomyelinase(s) as a virulence 
determinant and the association of sphingomyelinase activity with the cell also have 
prompted investigations to determine the potential of recombinant portions of these gene 
products as vaccines in a hamster challenge model. 
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CHAPTER 3: EVALUATION OF GENETIC VARIABILITY IN, 
AND EXPRESSION OF, sphA AND sphB IN Leptospira 
borgpetersenii SEROVAR HARDJO 
A paper to be submitted to Infection and Immunity 
David P. Alt, Ruud P. A. M. Segers, Eric KJaasen, Richard L. Zuemer, and Carole A. Boiin 
ABSTRACT 
Leptospira borgpetersenii serovar hardjo isolates (n=200) were examined by 
hybridization for restriction fragment length polymorphisms (RFLPs) in sphA, a leptospiral 
sphingomyelinase gene, and sphB, a related gene and putative sphingomyelinase. Two 
polymorphisms were seen in sphA among 200 isolates tested and nine polymorphisms were 
detected in sphB. Hybridization studies with sphA placed all but a single variant isolate in 
one RFLP type. Sequence analysis indicated the EIFLP type of the variant was due to the 
introduction of an insertion sequence. The RFLPs detected in sphB were localized to a 
region of tandem repeats. The region of tandem repeats was constructed in two different 
patterns. These patterns correlated with a restriction endonuclease analysis (REA) method 
previously described for classification ofZ.. borgpetersenii serovar hardjo. Isolates 
previously classified by REA as type A contained differing numbers of a 45 bp unit in the 
repeat region; those classified as REA type B contained a single 45 bp unit followed by 
differing numbers of a 30 bp unit. Sequence analysis of the 30 bp unit showed a high level of 
homology to the 45 bp unit with deletion of the initial 15 bp. Reverse transcriptase-PCR 
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demonstrated that sphA and sphB are transcribed by L. borgpetersenii serovar hardjo when 
grown in culture. Polyclonal antisera developed against recombinant SphA and SphB 
detected several protein bands when reacted by immunoblot with a Triton X-114 outer 
membrane extract of L. borgpetersenii serovar hardjo. The presence of multiple bands may 
indicate post-translational modification, protease digestion, or the presence of cross-reactive 
proteins in the extract. Findings reported here indicate that both SphA and SphB, possible 
leptospiral virulence factors, are transcribed, translated, and localized to the periplasmic 
space or outer membrane of L. borgpetersenii serovar hardjo. 
INTRODUCTION 
Leptospirosis is an important zoonotic disease of wild and domesticated animals caused 
by infection with one or more of the many serovars of Leptospira. The most common cause 
of bovine leptospirosis throughout the world is serovar hardjo (54. 141, 154). Infection has 
been associated with mastitis, decreased milk production, abortion, birth of weak calves, and 
infenility. Infection often becomes endemic in herds and is commonly subclinical (19). 
Serovar hardjo is a genetically diverse serovar and contains organisms that belong to 
two different species of Leptospira: L. interrogans serovar hardjo type hardjoprajitno (155) 
and L. borgpetersenii serovar hardjo type hardjo-bovis (119). These organisms are 
serologically indistinguishable, but genetically quite distinct. The two types of serovar 
hardjo can be distinguished fi-om one another by restriction endonuclease analysis (REA) of 
DNA (55, 103, 145). The distribution of infection with these two types of hardjo is quite 
different. Throughout the world, serovar hardjo type hardjo-bovis is the most common cause 
of bovine leptospirosis (54, 141, 154). In contrast, serovar hardjo type hardjoprajitao has 
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only been identified in the United Kingdom, a few places in Afiica, and Mexico. There is 
only a single report of serovar hardjo type hardjoprajitno isolated in the United States and 
this was firom a horse in California (92). 
Variability also has been demonstrated within type hardjo-bovis isolates using REA 
(143), resulting in classification of the isolates as REA types A or B. Type A isolates of 
hardjo-bovis are common throughout the world, but type B isolates are less common and 
most of the type B isolates are fi-om the United States (166). In a survey of the United States 
and Puerto Rico, 85% of isolates were identified as type A and 15% of isolates were type B 
(106). Genetic variability also has been demonstrated among isolates by hybridization with 
an insertion element (166). Differences found were consistent with the geographic regions 
fi-om which the strains were isolated suggesting the existence of several different clonal 
populations of type hardjo-bovis. Other techniques including randomly amplified 
polymorphic DNA fingerprinting (30, 62) and arbitrarily primed PCR (116) also have shown 
genetic heterogeneity among type hardjo-bovis isolates. 
Differences in the biologic behavior of infection with serovar hardjo type hardjo-bovis 
is apparent when different regions of the world are compared. In the United States, infection 
of cattle with serovar hardjo type hardjo-bovis may result in reproductive failure and 
decreased milk production. Human infections, while they may occur, are not commonly 
reported. However, in other parts of the world, the spectrum of disease produced by type 
hardjo-bovis infection varies. In the British Isles, disease in both cattle and man is corrunon 
and may be caused by either type hardjo-bovis or type hardjoprajitno (66). Throughout 
Europe, clinical infections with type hardjo-bovis are common in cattle while human 
infections are only common in The Netherlands (66). In Portugal, there is seemingly little 
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disease in cattle, but a high incidence of antibody titers is seen in cattle indicating a high 
infection rate (29). Disease in man is seen in Australia and New Zealand (100) while the 
disease is not clinically apparent in cattle (23, 38, 131). Experimental infection of cattle 
using serovar hardjo isolates from several parts of the world has shown differences in 
shedding pattern, tissue localization, histopatho logical lesions, and host humoral response 
(17). While management practices may play a role in the differences in clinical presentation 
of serovar hardjo infections, the observed differences in biological behavior may reflect 
variability among type hardjo-bovis isolates with respect to virulence and host adaptation. 
Although virulence factors have not been definitively described for Leptospira, 
leptospiral hemolysin(s) are considered potential virulence determinants. Both saprophytic 
and pathogenic leptospires may possess hemolytic activity. This activity is attributed to 
phospholipase A in the saprophytes while some pathogens demonstrate both 
sphingomyelinase and phospholipase A activity (90). 
Hemolysins and sphingomyelinases in other organisms play a role in virulence. In the 
spirochete Serpiilina hyodysenteriae, hemolysin—negative mutants have reduced virulence 
(79). Listeria monocytogenes, an intracellular pathogen, requires a pair of phospholipases, 
plcA and plcB, for optimal intracellular growth (132). Both plcA, a phosphatidylinositol 
specific phospholipase C, and plcB, a broad spectrum phospholipase C that can hydrolyze 
sphingomyelin, act synergistically (132). It is proposed that plcA allows escape from the 
double-membrane-bound vacuole encountered during cell to cell spread while plcB allows 
escape from the primary vacuole encountered on initial infection (132). The beta-toxin of 
Staphylococcus aureus, a sphingomyelinase, has been shown to be cytocidal and promote 
cytokine release in human monocytes (153). 
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Sphingomyelinase activity was demonstrated by thin-iayer chromatography using a 
Dutch field isolate L borgpetersenii serovar hardjo (strain Sponselee). This activity was 
associated with the cell pellet in strain Sponselee as opposed to the culture supernatant in L 
interrogans serovar pomona (strain Pomona) (167) and L. interrogans serovar canicola 
(strain Moulton) (158). Other studies using New Zealand isolates (73, 76) and a U.S. isolate 
(5) of type hardjo-bovis failed to demonstrate hemolytic activity. 
Several distinct genes encoding hemolytic activity have been cloned from Leptospira 
(32, 34, 60, 152). The gene, sphA, cloned by del Real et al. from type hardjo-bovis confers 
both hemolytic and sphingomyelinase C activity on Escherichia coli (34). Characterization 
of the cloned DNA fragment revealed putative -10, -35, and Shine-Dalgamo initiation 
sequences upstream of the open-reading frame (ORP), sphA. This ORF contains regions of 
homology at the nucleotide and amino acid levels to a pair of bacterial sphingomyelinases, 
the Staphylococcus aureus beta-toxin and an enzyme from three Bacillus cereus isolates 
(128). Hybridization studies using sphA demonstrated significant cross-hybridization with 
DNA from L. interrogans, L. borgpetersenii, L. weilli, L. santarosai, L. alstoni, and L. 
noguchi (126). These studies led to the discovery of an additional related gene in type 
hardjo-bovis (127), sphB, and four other related genes in L. interrogans serovar copenhageni 
(strain Wijnberg) (127). 
The chromosomal fragment detected by hybridization from type hardjo-bovis with sphA 
contained a partial ORF that showed homology with sphA and the S. aureus and B. cereus 
sphingomyelinase genes. However, the cloned fragment did not contain the -10, -35, Shine-
Dalgamo initiation sequences or the initiation codon, and did not demonstrate enzymatic 
activity when cloned in E. coli. Segers et al. described this ORF as a putative 
25 
sphingomyelinase and identified it as sphB (127). The lack of genetic transformation 
systems in Leptospira prevent experiments to delete or mutate sphA or sphB and determine 
effects on virulence. 
Based on hybridization studies with sphA, Gaastra et ai suggested the existence of a 
sphingomyelinase gene family that was divided into two groups: one group was found in L. 
interrogans. L. nogtichi, and L. alstoni; the second group was found in L. borgpetersenii, L. 
weillii, and L. santarosai (61). Of the pathogens tested, only L. inadai did not hybridize with 
sphA, while among saprophytes, only a single isolate ofL. meyeri demonstrated hybridization 
with this gene (126-128). 
The genetic variability of type hardjo-bovis isolates, differences in phenotypic 
expression of hemolytic activity, and the variability seen in clinical presentation of serovar 
hardjo infections have led us to investigate multiple isolates of serovar hardjo for differences 
in sphA and sphB. The overall purpose of the studies proposed here was to examine a large 
collection of geographically diverse type hardjo-bovis isolates to determine if there is 
variation in sphA and sphB and whether these differences might correlate with pathogenicity 
of type hardjo-bovis isolates. In addition, we wanted to determine if these genes are 
expressed during in vitro growth. 
MATERIALS AND METHODS 
Materials. Triton X-100 and Triton X-114 were obtained from Sigma Chemcial Co. 
(St. Louis, Mo.). MetaPhor XR agarose was obtained from FMC Bioproducts (Rockland, 
Me.). Hybond-N, ECL™ detection reagents, and the Megaprime DNA Labeling Kif"^' were 
obtained from Amersham Life Science, Inc. (Arlington Heights, 111.). XL-I Blue competent 
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Escherichia coli and plasmid pBCKS- were purchased from Stratagene Cloning Systems (La 
Jolla, Calif.). The TA cloning kit, Xpress™ kit, and plasmid pRSetB were purchased from 
Invitrogen (Carlsbad, Calif.). The Access RT-PCR kit and the E. coli T7 S30 Extract System 
for circular DNA were purchased from Promega Corp. (Madison, Wise.). En^hance was 
obtained from Dupont (Boston, Mass.). Radioactively labeled [a-"P]ATP and [''*C]leucine 
were purchased from ICN Biomedicals, Inc. (Costa Mesa, Calif.). The Universal Genome 
Walker™ kit and the CLONsep kit were purchased from Clontech Lab., Inc. (Palo Alto. 
Calif) Centricon 10 kDa molecular weight cutoff concentrators were obtained from Amicon 
Inc. (Beverly, Mass.). Biomax MR film was obtained from Eastman Kodak Co. (Rochester, 
N.Y.). PLM5 medium was purchased from Intergen Corp. (Purchase, N.Y.). TV-Tag® 
antibody HRP conjugate was purchased from Novagen (Madison, Wise.). Immobilon™-P 
was purchased from Millipore Corp. (Bedford, Mass.). MPL® + TDM + CWS Emulsion (R-
730) was obtained from RIBI ImmunoChem Research, Inc. (Hamilton, Mont.). Rabbit 
polyclonal antiserum to glutathione S-transferase (GST) and the GST-fusion protein, GST-
SphA, were provided by Dr. Ruud Segers, (Department of Bacteriological Research, Interx'et 
International B.V. Boxmeer, The Netherlands). 
PreparatioD and analysis of genomic DNA. To screen for restriction fragment length 
polymorphisms (RFLPs), Southern hybridization was performed using genomic DNA from 
field isolates of L. borgpetersenii serovar hardjo type hardjo-bovis. Genomic DN.A. used in 
all procedures was prepared as previously described (144). DNA preparations were prepared 
from isolates available in the culture collection of the National Animal Disease Center 
(Ames, la.). Isolates representing the RFLPs characterized are listed in Table 3.1. 
27 
TABLE 3.L Bovine isolates of Leptospira borgpetersenii serovar hardjo representative of 
RFLPs detected in this study. 
Isolate designation Source of original isolate 
033 (Clone RZ33)' 
117 
203 
Sponselee 
005 
113 
045 (Clone 045)" 
300 
085 
197 (Clone JB)" 
145 
Colorado 
Florida 
Kansas 
The Netherlands 
Illinois 
Florida 
Iowa 
Kansas 
Florida 
Nebraska 
Northern Ireland 
"Clones represent colony purified isolates. 
DNA was digested with either fcoRI or Hhal and was separated by continuous-field 
gel electrophoresis in a horizontal gel box as previously described (143). Fractionated DNA 
was transferred by blotting to Hybond-N and hybridized with radiolabeled probes using 
similar methods to those previously described (165). 
Radiolabeled probes were prepared using plasmids pHL2-B3 (128) or pSS17Hl (127) 
as template in probe synthesis (Fig. 3.1). Probes were labeled with [a-^^P]ATP by random 
priming using the Megaprime DNA™ labeling kit. 
DNA was immobilized by UV crosslinking to Hybond-N, prehybridized for at least 4 h 
at 56°C in 6X SSC (102), 0.1% SDS (v/v), and 2.5% nonfat dry milk (w/v). Hybridization 
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Figure 3.1: Schematic representation of construction ofplasmids pSIXl and p2728B as 
described in the text, (a) top: Plasmid pHL2-B3 showing orientation of 3.9 
kb BamHl fragment containing sphA (shaded arrow) and T7 promoter (shaded 
arrowhead). 5acl and Xhol cleavage sites are indicated, bottom: Plasmid 
pSlXl showing orientation of SacUXhol insert in pBCKS-, containing 
BamYH fragment from pHL2-B3. Orientation of sphA (shaded arrow) and T7 
promoter (shaded arrowhead). Sad, Xhol, and BamHl sites are indicated, (b) 
Plasmid p2728B showing orientation of sphB (shaded arrow) and T7 promoter 
(shaded arrowhead) in pCR2.1. Primers 27 and 28 used to amplify the 
sequence including sphB are indicated (empty rectangles). Not drawn to scale. 
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with radioactively labeled probes was performed overnight in the same solution at 56°C. 
Washing consisted of one 5 min wash with 6X SSC, three 5 min washes with 2X SSC, and 
four 15 min washes with 2X SSC containing 0.1% SDS. All washing steps were performed 
at 56°C. Excess wash solution was removed from tlie blots. Blots were wrapped in plastic-
wrap and exposed to Biomax MR fihn at -70°C for varying periods of time. Isolates 
demonstrating RFLPs were identified and used for further analysis. 
Cloning and analysis of PCR products. To further characterize the RFLPs detected 
through hybridization with £coRI-digested leptospiral genomic DNA, genomic DNAs from 
isolates representative of different RFLPs were used as template DNA in PCR with primers 1 
and 3 (Table 3.2). Primer I was generated using additional sequence upstream of sphB 
(Ruud Segers, personal communication). Product from these reactions was digested with 
either Haelll or Hhal ovemight. Resulting digestion products were separated by continuous-
field gel electrophoresis in 4% MetaPhor XR agarose, stained with ethidium bromide, and 
photographed. 
PCR products amplified from genomic DNA of isolates representing the different 
RFLP patterns for sphB were cloned into pCR 2.1 using the TA cloning kit, according to 
manufacturer's instructions. Clones were selected, and plasmid preparations were analyzed 
by EcoRI digestion to check for the presence of an insert of similar size to the PCR product. 
Plasmids containing cloned PCR products were purified by CsCl centrifugation (10) and used 
for sequencing at the DNA Sequencing Facility of Iowa State University (Ames, la.) using an 
ABI PRISM™ Model 377 DNA sequencer (Perkin-Elmer Norwalk, Conn.). 
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TABLE 3.2. PCR primers. 
Primer^ Sequence (5'-3') Tm" Target 
1 5'-TAC-CTC-ACG-TTG-TTT-ACC-TG-3' 46 sphB 
3 5'-CAG-TGT-TTG-GTG-GAA-TGT-AG-3' 46 sphB 
17 5'-CTG-ACT-TTC-GTC-GCT-TAC-GC-3' 54 sphB 
18 5-TTA-CAA-GCG-CGT-CCC-TAA-GTC-C-3' 73 sphB 
23 5'-AGA-ACT-TAC-AGA-GCC-AGA-AC-3' 62 sphA 
26 5'-GGT-GAA-AGT-CAT-CTA-GCC-TGT-GC-3' 55 sphA 
27 5'-CGC-CAA-TAG-AAG-CGA-GAC-GC-3' 58 sphB 
28 5'-TGC-AAA-CTT-GTC-GAT-GAT-TAC-AGC-3' 57 sphB 
34 5'-AGG-AGT-TGT-TAT-TGT-AAG-TA-3' 55 sphA 
35 5'-GAA-TAT-GTA-ATC-CAA-GTA-TG-3' 55 sphA 
36 5'-AAC-ATA-AAG-ACA-TCA-TAG-TA-3' 55 sphB 
37 5'-ATT-GTC-GAA-GAT-GTA-TTG-TA-3' 59 sphB 
Iowa State University DNA Sequencing Facility, Ames, la. 
Melting temperature in degrees centigrade (59) 
Characterization of RFLPs in sphA and analysis of sphB structural gene and 
upstream sequences. To characterize the RPLPs detected by hybridization of EcoRl 
leptospiral genomic DNA digests with an sp/iA specific probe, primers oriented upstream of 
sp/iA were designed and used with the Universal Genome Walker™ kit. Briefly, leptospiral 
genomic DNA was digested using restriction endonuclease enzymes provided with the kit. 
Digested leptospiral DNA was precipitated using ammonium acetate. The pelleted DNA was 
washed sequentially with 95% and 70% ethanol and suspended in sterile distilled H,0. 
Digested DNA was then ligated to an adaptor provided in the kit. The adaptor contains 
known PCR primer sequences, and primers to these sequences also are included in the kit. 
PCR was used to generate fragments of sp/iA upstream region using a kit primer and primer 
23 or 26 (Table 3.2). The PCR products were ±en cloned into pCR 2.1. Clones containing 
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the PCR product were confirmed by EcoRl digestion, and CsCI purified plasmids were 
sequenced. 
To characterize the remainder of the sphB ORP and check for the presence of sequence 
similar to those upstream of sphA, additional sequence information was needed. Additional 
sequence to that provided by Dr. Segers was obtained and compared to that of sphB in 
serovar hardjo (strain Sponslee). This sequence was obtained by using the genome walker kit 
and either primer 17 or 18 (Table 3.2). The resulting sequence data allowed selection of 
primers 27 and 28 (Table 3.2). These two primers amplified the sphB ORF including 
upstream sequence. 
Plasmids and plasmid constructioii. Plasmids pHL2-B3 and pSS17Hl were obtained 
from Dr. Ruud Segers (Fig. 3.1). Plasmid pHL2-B3 contains sphA, an ORF of 1,668 
nucleotides, within a 3.9 Kb BamHI fragment of L. borgpetersenii serovar hardjo (strain 
Sponselee) genomic DNA. Plasmid pSS17Hl contains sphB, a partial ORF of 2,283 bp, 
within a 2.5 Kb HincHXl fragment also from strain Sponslee. Plasmid pRSet B and plasmid 
pBCKS- were used in construction of recombinants. Plasmid pCR2.1 was obtained as part 
of the TA cloning kit and was also used in construction of recombinants. 
Plasmid pHL2-B3 (Fig. 3.1) containing ORF sphA was digested with Xhol and 5acl, 
precipitated and ligated into a similarly digested plasmid pBCKS-, creating plasmid pXlSI 
(Fig. 3.1). This plasmid contained the entire BamRl insert ft'om pHL2-B3 oriented 
downstream of a T7 promoter. Presence of the insert was confirmed by BamHl digestion. 
The PCR product from amplification of DNA from strain Sponselee with primers 27 
and 28 (Table 3.2) was also ligated into pCR 2.1, as above, producing plasmid p2728B (Fig. 
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3.1). Proper orientation of the insert downstream of the T7 promoter in pCR 2.1 was 
confirmed by sequence analysis. 
Piasmids pSSI 7HI and pBCKS- were digested overnight using SaH. and HindUl. The 
fragment containing a portion of sphB was ligated into plasmid pBCSK- with selection on 
DYT agar (8 g bacto tryptone, 5 g bacto yeast extract, 5 g NaCl, and 10 g Bacto agar in 500 
ml sterile distilled H^O) and chloramphenicol at 30 /^g/ml. Colonies were selected firom an 
overlay of 3 ml of DYT top agar with 0.6% agar containing 30 yug/ml chloramphenicol with 
10 Ail of 100 mM isopropyl P-D-thiogalactopyranoside and 60 lA of 50 mg/ml 5-bromo-4-
chloro-3-indolyl P-D-galactopyranoside in N,N dimethylformamide added. White colonies 
were selected and piasmids were prepared. Presence of the appropriate insert was determined 
by restriction endonuclease digestion. The resulting chloramphenicol resistant plasmid 
pSlH3 (Fig. 3.2) contained the SaWHindW. fragment from pSSHlTl. 
To clone under isopropyl p-D-galactopyranoside control and keep sphB in frame, 
plasmid pRSetB and plasmid pS 1H3 containing the SaHJHindUl fragment were both digested 
using .\7ioI and HindUl. The resulting fragment from pSlH3 was ligated into pRSetB and 
transformed into competent XL-1 Blue E. coli cells with selection from DYT top agar 
overlayed on DYT agar plates, both containing 100 A^g/'ml of ampicillin. Colonies were 
picked and recombinant piasmids analyzed for the presence of the proper insert. The 
fi^gment was oriented in the vector by DNA sequence analysis. The resulting plasmid 
contained the SalllHindlW fragment from pSS17Hl and a small portion of the multiple 
cloning site from pBCSK-. This plasmid was designated pAXH3 (Fig. 3.2). 
In vitro translation. To compare molecular masses of SphA and SphB with those 
predicted by sequence analysis, in vitro translation was performed. This required CsCl-
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Figure 3.2: Schematic of construction of plasmid pAXH3 as described in the text. 
top: Plasmid pSSlTHl showing 2.5 kb Hindlll fragment containing 
sphB (shaded arrow), SaU sites are also shown. 
middle: Plasmid pSlH3 containing 1.6 kb Sall/Hindlll fragment from 
pSSlTHl showing orientation of sphB (shaded arrow) and 
location of Hindlll, SaU, and Xhol restriction sites. 
bottom: Plasmid pAXH3 containing 1.6 kb Xhol/Hindlll fragment 
from pS IH3 showing orientation of 5p/i5(shaded arrow) and 
T7 promoter (shaded arrowhead). Not drawn to scale. 
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purification of plasmids pBCKS-; pXlSl, containing the entire BamHl fragment from 
pHL2-B3; pCR 2.1; and p2728B. Using the E. coli T7 S30 Extract System for circular DNA 
['•*C]Ieucine was used to label the resulting translation products. Ten u\ of the labeled 
product was separated by SDS-PAGE. The gel was stained for 2 h in 0.125% coomassie 
brilliant blue R-250 in 50% methanol and 10% glacial acetic acid, and destained overnight in 
5% methanol and 7.5% glacial acetic acid in distilled HjO. The gel was soaked twice for 10 
min each in 50% methanol and 30% acetic acid with gentle agitation. This was followed by 
soaking for 2 h in 3 gel volumes of En^hance with agitation. The gel was then agitated in 6 
gel volumes of distilled H^O for 1 h, was mounted and dried on gel blot paper using a 
vacuum dryer. The gel was then exposed to Biomax MR film at -70^C for 7 days. The film 
was developed and examined for the presence of bands consistent with the expression of 
radiolabeled proteins. Unlabeled in vitro translation reaction products for sphB were 
evaluated for hemolytic activity using blood-agar plates containing 25 mM MgCU as 
described by Segers (128). Five u\ of unlabeled sphB reaction product were dropped onto the 
surface of the blood agar plates. Plates were incubated overnight at 37°C followed by 8 h at 
4"C and were then evaluated for the presence of hemolysis. 
Reverse transcriptase-PCR (RT-PCR) and analysis of in vitro leptospiral 
e.vpression of spit A and sphB. To detect transcripts corresponding to sphA and sphB present 
in serovar hardjo grown under culture conditions, we performed reverse transcriptase-PCR. 
RNA was isolated from hardjo strains Sponselee, 033, and 197 by extraction from 100 to 150 
ml of actively growing leptospiral cells grown in PLM5 medium at 29°C. Cells were 
harvested by centrifugation at 39,000 x g for 15 min at 4°C in a JA-17 rotor using a Beckman 
J2-21 centrifuge. The cells were washed once using an equal volume of sterile PBS (pH 7.2) 
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and pelleted again. The cell pellet was processed using the CLONsep kit (Appendix B) (24, 
25, 31, 123, 158). Cells were resuspended in a sterile 50 ml conical tube on ice using 3 ml 
CLONsep A solution. The cells were then held at room temperature for 5 min, followed by 
centrifligation at 7,300 x g for 15 min at 4°C in a JS-7.5 rotor using a Beckman J2-21 
centrifuge. The supernatant was removed, and the pellet then was resuspended in 2 ml of 
CLONsep B solution on ice. The suspension was held at room temperature for 5 min, 6 ml 
of chloroform were added, and the mixture was shaken for 10 seconds and cooled on ice for 
15 min. The suspension was again centrifuged at 7,300 x g- for 15 min at 4°C. The upper 
aqueous phase was transferred to a new sterile 50 ml conical tube, and 1/3 volume of 95% 
ethanol was added dropwise to the supernatant. The solution was thoroughly mixed and 
stored at -20°C for 1 h, followed by centrifugation at 7,300 x g for 15 min at 4°C. The 
supernatant was removed, and the RNA pellet was washed with 5 ml of ice-cold 75% 
ethanol. This was followed by centrifugation at 7,300 x g for 15 min at 4'^C with removal of 
the supernatant and air-drying for 5 to 10 min. The pellet was suspended in 250 to 500 ul of 
DEPC treated sterile distilled H,0. 
RT-PCR was performed using the Access RT-PCR kit with modifications for removal 
of contaminating DNA (37). A control reaction lacking reverse transcriptase was done to 
ensure absence of contaminating DNA in the RNA preparation. 
Antigen and polyclonal antiserum preparation. Purified plasmid pAXH3 was 
transformed into competent XL-1 Blue £. coli cells by placing 2 /^1 of the plasmid with 50 u\ 
of competent cells on ice for 30 min followed by 2 min in a 37°C water bath. One ml of 
DYT liquid medium was added, and the cells were allowed to incubate for 1 h at room 
temperature. The cells were then suspended in DYT top agar containing 100 /^g/ml of 
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ampicillin over DYT plates also containing 100 Mg/ml of ampicillin. Ampicillin resistant 
colonies were picked and evaluated for presence of the appropriate plasmid and insert size by 
restriction endonuclease digestion and analysis. Recombinants were grown, induced, and 
processed according to the denaturing protocol (Appendix B) supplied with the Xpress™ kit. 
A batch method was followed with eluent dialyzed overnight against 0.1 M Tris-HCl (pH 
8.0) with 0.1% Triton X-100. The resulting solution was concentrated using a centricon 10 
kDa molecular weight cutoff concentrator. This preparation was checked for presence of 
fusion protein by immunoblotting. T7-Tag® antibody HRP conjugate was used to probe and 
confirm the presence of a tagged protein in the concentrate consistent in size with the 
expected 56 kDa fusion protein (data not shown). 
The concentrated fusion protein AXH3 was emulsified with MPL® + TDM + CWS 
Emulsion (R-730) according to manufacturer's directions at a concentration of 0.2 mg/ml of 
recombinant protein. A six-month-old female rabbit was checked for the presence of 
agglutinating antibodies to Leptospira by the microagglutination test (MAT) (28). The rabbit 
was subsequently immunized on day 0, and this was repeated 5, 9, and 13 weeks later. The 
rabbit was euthanized and the serum harvested 16 weeks after the first immunization. The 
polyclonal antiserum was checked for reactivity by immunoblot to the protein preparation 
used for immunization. Secondary antibody used in the immunoblot was 1:5,000 horseradish 
peroxidase-labeled goat anti-rabbit IgG. 
Triton X-114 outer membrane preparation. The procedure used was similar to that 
previously described (167). Briefly, 100 ml of mid-log to late-log phase cells were harvested 
by centrifugation at 35,300 x g at 4°C using a JA-17 rotor in a 52-21 centrifuge. Cell pellets 
were resuspended in 10 ml cold TBS (50 mM Tris-HCl, pH 7.2, and 150 mM NaCl), 
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centrifuged, and the procedure repeated once more. The washed cell pellet was then 
suspended in 2 ml ice-cold 2% Triton X-114 in TBS. This suspension was held on ice for 20 
min with occasional mixing. Protoplasmic cylinders were removed by centrifugation at 
13,800 X ^ for 15 min at 4°C. The supernatant was removed to a clean tube and 
centrifugation was repeated. Phase separation was not performed. 
SDS-PAGE and immunobiotting. SDS-PAGE was performed using a tris-tricine-
buffered system with a 10% resolving gel and a 5% slacking gel (124). Gels were run 
overnight at 15 mA followed by 3 to 5 h at 70 to 100 mA. Samples were denatured in sample 
buffer (4% SDS, 12% glycerol, SOmM Tris-base, pH 6.8,2% 2-mercaptoethanol, and 0.005% 
bromphenol blue) at 100°C for 5 min. 
Proteins were transferred to Immobilon™-P using a semi-dry transfer system and 
transfer buffer (39 mM glycine, 20% methanol, 0.0375% SDS, and 48 mM Tris-base) at 200 
mA for 1.5 to 2 h. Immunoblots were processed according to instructions included with the 
ECL™ kit. 
RESULTS 
RFLP detection and characterization, (i) s/7/r.4-DN.A/DNA Hybridization. 
Hybridization using radiolabeled plasmid pHL2-B3 containing the ORF sphA demonstrated 
that all isolates (n=I99), except isolate 005 (n=I), were of the same hybridization pattern 
(Fig. 3.3). PGR primers were designed to amplify the region containing the polymorphisms. 
(ii) Sequencing of the poiymorphic region of sphA. Primers 23 and 26 (Table 3.2) 
were used to genome walk upstream of the region containing the ORP sphA in isolates 005 
and 033 (Clone RZ33), the type strain for serovar hardjo. The PGR product was ligated into 
Figure 3.3: Comparison of L borgpetersenii serovar hardjo strains by DNA hybridization with sphA probe. DNA was digested 
with EcoR\ or Hha\, separated by agarose gel electrophoresis, and transferred to Hybond-N as described in the text. 
The blot was hybridized with [a-^^P]pHL2B3. Lanes 1-8 are £'coRI digestion products. Lanes 9-16 are Hha\ 
digestion products. Lanes 1,9, strain 117; Lanes 2,10, strain 203; Lanes 3,11, strain Sponselee; Lanes 4,12, strain 
005; Lanes 5,13, strain 045; Lanes 6,14, strain 113; Lanes 7,15, strain 197; Lanes 8,16, strain 145. Kb is the 
kilobase marker. 
Kb 1 2 3 4 5 6 
2036 
1636 
1018 
m. 
506 _ 
517 ~ f 
Kb 9 10 11 12 13 14 15 16 
u> VO 
# 
40 
pCR2.1. and the resulting plasmid sequenced. The sequence for these isolates is compared 
(Fig. 3.4) and presented schematically (Fig. 3.5). Sizes predicted from sequence generated 
for the £coRI fragment in isolate 005 is 1,334 bp and for the Hhal fragment is 1,698 bp. 
These are in agreement with the fragments detected by hybridization (Fig 3.3). 
Primers 17 and 18 (Table 3.2) were used to genome walk upstream of the region 
containing ORF sphB in isolate 197 and isolate 033. This sequence is compared with the 
additional sequence provided by Dr. Segers (Fig. 3.6). 
(iii) s/»/i5-DNA/DNA hybridization. Hybridization analysis of 200 different strains 
of serovar hardjo demonstrated that there were nine different patterns of the EcoRl fragments 
containing sphB sequence. Analysis of eight of these strains is shown in Fig. 3.7. Isolate 
085 is not shown but was cloned and sequenced. The size of fragments reported to hybridize 
with sphB in strain Sponselee are 1.6, 0.7, and 0.4 kb (127). A hybridizing band is detected 
for strain Sponselee at these sizes, but variability with respect to the largest fragment is seen 
among the isolates evaluated. Nucleotide sequence for pSS17Hl and additional upstream 
sequence reveals £coRI sites that yield fragments of 462 and 745 bp (Fig. 3.8). accounting 
for the 0.4 and 0.7 kb fragments. In addition, fragments of at least 1,263 bp and 271 bp are 
indicated. The 1,263 bp fragment contains a region of tandemly repeated 45 bp elements 
(127). PCR primers were designed to flank this region in order to help localize the area of 
polymorphism. Primers 1 and 3 were used for the analysis and are listed in Table 3.2. 
(iv) PCR. PCR products from representative isolates were digested using restriction 
enzymes HaeHl and Hpall. The expected PCR product for strain Sponselee should yield 
digestion products of 548, 159, and 65 bp for HaelR and 221, 101, and 45 bp for Hpall as 
diagrammed (Figs. 3.9 and 3.10, respectively). The results of the digestion are also shown in 
Figure 3.4: Sequence alignment of the region upstream of sphA in L. borgpetersenii 
serovar hardjo isolates 005, 033, and strain Sponselee. Sequence in bold 
is homologous to L. interrogans IS elements by BLASTn and BLASTx 
(6). Within the sequence, a - represents an inserted gap in the sequence. 
Beneath the sequence, a * represents an identical base for the three 
sequences compared and an X indicates lack of homology in at least one 
sequence. Underlined sequence indicates the EcoRl restriction site within 
strain 005. Sequences were aligned using CLUSTAL X (1.5 b). 
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005 ATCCTCGGAAAGGATTGATCTTTCATTCTGATCGGGGTTCTAATTTTTGTTC 
033 
Sponselee 
005 TAAAGAAACACGCAAATTACTGATTGCTAACGGTATCAGGCGAAGCAACAGC 
033 
Sponselee 
005 AGAAAAGGAAATTGTTGGGACAATGCAGTGGCAGAGTCTTTCTTTAGTTCTC 
033 
Sponselee 
005 TAAAGAGAGAAATCGaAIICAATACATTCTATAACATTGAAGAAGCGGAGCG 
033 
Sponselee 
005 CTTTCTATTCGGTTTTATCGAAGTGTATTACAATAGATTCAGGCTTCATTCT 
033 
Sponselee 
005 ACATTAGGTTATATGAGCCCTGAAGAATTTGAGAGAAATATTGCTTAAAAGG 
033 ATCTGGGCGGAACTAGGACATCTTTATTAT 
Sponselee 
005 CTGTCCACTTTTATGTGACTTCTTCAGGTTTCCCTCAAAACGTCGATGCGTA 
033 CAAAGGGGAAATTACAACTCTGCACTGGTTTCCCTCAAAACGTCGATGCGTA 
Sponselee 
005 TGGATAGCGACGAGAATTTTCTTCATTACGATATGATTGCTCAGTGTTATCT 
033 TGGATAGCGACGAGAATTTTCTTCATTACGATATGATTGCTCAGTGTTATCT 
Sponselee 
005 GAAAGTGTCTGATCACAAAAATGCCCTTAAGTTCATCGATTTATATGGTCAG 
033 GAAAGTGTCTGATCACAAAAATGCCCTTAAGTTCATCGATTTATATGTTCAG 
Sponselee 
005 TATTTTGGAGAGTCCGATTCAGACATTCTAATTATCAAAGCACGAGCTCACG 
033 TATTTTGGAGAGTCCGATTCAGACATTCTAATTATCAAAGCACGAGCTCACG 
Sponselee 
005 CTCAACTCGGTGAAAGTCATCTAGCCTGTGCATCCTTATTACAGGCATATTC 
033 CTCAGCTCGGTGAAAGCCATCTAGCCTGTGCATCCTTATTACAGGCATATTC 
Sponselee 
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005 CATGGAAAAT.GGCCTCAAACTGAACGCGGAAQACATGGTCGATTTTGCACCT 
033 GCATGGAAAATGGCCTCAAACTGAACGCGAAGACATGGTCQATTTTGCACCT 
Sponselee 
005 TTACTTCAAACCGGTTTTTTTGATACATTAGAAAACGTTGAAATAGAAGAGC 
033 TTACTTCAAGCCGGTTTTTTTGATACATTAGAAAACGTTGAAATAGAAGAGC 
Sponselee 
005 CTTAAACGGATTTGAAAGATTGTTCGGCGGATCCTTTTTTCGTTATTTTTAC 
033 CTTAAACGGATTTGAAAGATTGTTCGGCGGATCCTTTTTTCGTTATTTTTAC 
Sponselee GGATCCTTTTTTCGTTATTTTTAC 
005 TAAGAATTTGTTCCAAGGACGTGGAAACTTTTACGTTTTAGATGTTCGTGGA 
033 TAAGAATTTGTTCCAAGGACGTGGAAACTTTTACGTTTTAGATGTTCGTGGA 
Sponselee TAAGAATTTGTTCCAAGGACGTGGAAACTTTTACGTTTTAGATGTTCGTGGA 
it***'**-***'*'*'***'*-*'**'*-*-*'***-*-*****'**'**'*-**'*'***'***-**-**-**** 
005 TAGAACTTTTTTGCTCCTAATTTTGTTCATCAAGTAGCTTGATCTTTGTAAA 
033 TAGAACTTTTTTGCTCCTAATTTTGTTCATCAAGTAGCTTGATCTTTGTAAA 
Sponselee TAGAACTTTTTTGCTCCTAATTTTGTTCATCAAGTAGCTTGATCTTTGTAAA 
005 TCTGATTTGAGAACTTTTTACATTACATACAAGTCCATAAAACGCCATATAT 
033 TCTGATTTGAGAACTTTTTACATTACATACAAGTCCATAAAACGCCATATAT 
Sponselee TCTGATTTGAGAACTTTTTACATTACATACAAGTCCATAAAACGCCATATAT 
005 GCTTGAAGTCGATTTCTAATTTCTTGTGGAACGATTTTTGAAATGATGAAAT 
033 GCTTGAAGTCGATTTCTAATTTCTTGTGGAACGATTTTTGAAATGATGAAAT 
Sponselee GCTTGAAGTCGATTTCTAATTTCTTGTGGAACGATTTTTGAAATGATGAAAT 
005 ATATATTATATTTTTAATATAATATAGCTTATAAAAGCCGTTTAATCTGCCC 
033 ATATATTATATTTTTAATATAATATAGCTTATAAAAGCCGTTTAATCTGCCC 
Sponselee ATATATTATATTTTTAATATAATATAGCTTATAAAAGCCGTTTAATCTGCCC 
Figure 3.4 (Continued) 
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005 GGTGTGGGATTTCAAAAATCATAAAAAGATTAGAAATCGTTTTTATATGACA 
033 GGTGTGGGATTTCAAAAATCATAAAAAGATTAGAAATCGTTTTTATATGACA 
Sponselee GGTGTGGGATTTCAAAA - TCATAAAA - GATTAGAAATCGTTTTTATATGACA 
005 TACGATTATCAAATTTCTTCATTTAATCTTGAAACATGATCTAAJUUVGTAAA 
033 TACGATTATCAAATTTCTTCATTTAATCTTGAAACATGATCTAAAAAGTAAA 
Sponselee TACGATTATCAAATTTCTTCATTTAATCTTGAAACATGATCTAAAAAGTAAA 
005 CAAAGACTTTGTTCGCTTTTAATTTGTTTATTTTTATACACTTAAAATTTTG 
033 CAAAGACTTTGTTCGCTTTTAATTTGTTTATTTTTATACATTTAAAATTTTG 
Sponselee CAAAGACTTTGTTCGCTTTTAATTTGTTTATTTTTATACATTTAAAATTTTG 
•k ie ie ic "k "k ie ir ie ic "k ic ie ir ic ie ie ie ie it ie ie if ie ie ie it ie "k "k "k ie it it "k it it it "ie itie it ir "k ie "k ie "k ie it 
005 AAGGTTGCTTTAGGAATTGGCATTTTTAATTTCAATTACTTGAGCGTTATAT 
033 AAGGTTGCTTTAGGAATTGGCATTTTTAATTTCAATTACTTGAGCGTTATAT 
Sponselee AAGGTTGCTTTAGGAATTGGCATTTTTAATTTCAATTACTTGAGCGTTATAT 
005 GAAATTGATTCGTTTTTATAAAATACTCTTCTTCTTGTTGAACTCTATGTTA 
033 GAAATTGATTCGTTTTTATAAAATACTCTTCTTCTTGTTGAACTCTATGTTA 
Sponselee GAAATTGATTCGTTTTTATAAAATACTCTTCTTCTTGTTGAACTCTATGTTA 
ieieicickickkkiekkki t ieiekieieieickkkkkieieiei tkiekieieiekkkkkkkkkkkkieiricie  
005 TAGTATGGGCATTGATTTAAAAAGAATGGAGATAGTGTATGAGAATAAAAAA 
033 TAGTATGGGCATTGATTTAAAAAGAATGGAGATAGTGTATGAGAATAAAAAA 
Sponselee TAGTATGGGCATTGATTTAAAAAGAATGGAGATAGTGTATGAGAATAAAAAA 
i t ieici tkkiekk'kki t ieie 'ki tkki tkkkkkkkirkkki tkkkiei tkk 'kirkkkiekiek 'kkieieir  
005 ATATACAAAAGTGAGACTTCTTGTAAATTGTTGTCTCTTATTATTTTTTCTA 
033 ATATACAAAAGTGAGACTTCTTGTAAATTGTTGTCTCTTATTATTTTTTCTA 
Sponselee ATATACAAAAGTGAGACTTCTTGTAAATTGTTGTCTCTTATTATTTTTTCTA 
kkkkiei tki t i t icki t ici t iei t ickicickiekkkkkki tkicieieieiciekkkirkkk'kkkkkkkie* 
Figure 3.4 (Continued) 
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005 ATAGATTGTGGAGCCGATAGACAATCTTTGTATAAAGATTTACTTGCGTCTC 
033 ATAGATTGTGGAGCCGATAGACAATCTTTGTATAAAGATTTACTTGCGTCTC 
Sponselee ATAGATTGTGGAGCCGATAGACAATCTTTGTATAAAGATTTACTTGCGTCTC 
005 TAATTTACATTTCAGATAATAAAAACATTGGTTCTACAAATTCTGATTTAAC 
033 TAATTTACATTTCAGATAATAAAAACATTGGTTCTACAAATTCTGATTTAAC 
Sponselee TAATTTACATTTCAGATAATAAAAACATTGGTTCTACAAATTCTGATTTAAC 
**•************••*••**••*•*****•*•*****•*•**•*••**•*••*••*•***•*•*•****•* 
005 GGGTTCTGGCTCTGTAAGTTCT 
033 GGGTTCTGGCTCTGTAAGTTCT 
Sponselee GGGTTCTGGCTCTGTAAGTTCT 
********************** 
Figure 3.4 (Continued) 
46 
1—I I I I I 1 I 1 1—I—I—i—^i r - Sponsdee 
 ^(772 bps) 
Sa^jmcecSvagBnce /vwjr 
I—I—I—r-^i 1 1 1—I—I—I 1—I—I 1 1—I 1—I 1—I 1 1 1— 033*^ 
(1194bps) 
£odSl 
"I—I—r^-]—I—I—r^i—I—I—I—I—I—I—I—I—I—I—I—I—i—I—I—[—I—I—I—j—r- OOS 
:^ > (1479bps) 
aij -wo oco aco locu mo i4i) 
_i I I I I 1 u_l I I I ! I I I i ' ' ' ! I ' I I I'll' 
Figure 3.5: Schematic representations comparing the DNA sequence of the region 
upstream of sphA in L. borgpetersenii serovar hardjo strain Sponselee, strain 
005. and strain 033. The open arrow indicates the point of sequence 
divergence between strains 005 and 033. The IS element related sequence is 
shown as a forward diagonally hatched arrow. Hie £coRI restriction site in 
strain 005 is also indicated. 
Figure 3.6: Sequence alignment of region upstream of ORF sphB in three strains of L. 
borgpetersenii serovar hardjo. Sponselee is abbreviated as Spo. The letter 
X beneath the sequence indicates a difference in sequence between 033 
and 197. The start codon fox sphB is in bold and the portion of sphB 
included here is underlined. Upstream sequences similar to those found 
upstream of sphA (128) are shown in bold and underlined. An inverted 
repeat is indicated by x . Sequences were aligned using 
CLUSTAL X (1.5b). 
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033 AAAAACGCTTTAAGAAAAAAGTGCAGGCATCGATGATAGATGCGTGTTTT 
197 AAAAACGCTTTAAGAAAAAAGTGCAGGCATCGATGATAGATGCGTGTTTT 
Spo 
033 TACTCTAACACAATACAATAGAGTTGTTGAAGAATTAATTCTCTATCCGT 
197 TACTCTAACACAATATAATAGAGTTGTTGAAGAATTAATTCTCTATCCGT 
Spo 
X 
033 TTCTGCTGCATTAAAATGGACGTTTGAAGCGGTTTTGTTAATCTGAATCA 
197 TTCTGCTGCATTAAAATGGACGTTTGAAGCGGTTTTGTTAATCTGAATCA 
Spo 
033 TGGAATTTTTCAACAACTCTAATAGAGTTCATAAAACATCCTTTCTTTTT 
197 TGGAATTTTTCAACAACTCTAATAGAGTTCATAAAACATCCTTTCTTTTT 
Spo 
033 CTATCGTGAGTATAGAGACACTTTCAATTTCATCTTTCGTCCTGTCATCG 
197 CTATCGTGAGTATAGAAACACTTTCAATTTCATCTTTCGTCCTGTCATCG 
Spo 
X 
033 AAGATTACGAATATATATTGATCGATCCACCTAAGCCCATTGCTTCTGTC 
197 AAGATTACGAATATATATTGATCGATCCACCTAAGCCCATTGCTTCTGTC 
Spo 
03 3 CTAAATATAACATGAGTTCGACGTGACAAATGCGAAAGCGATGATTATGC 
197 CTAAATATAACATGAGTTCGACGTGACAAATGCGAAAGCGATGATTATGC 
Spo 
033 GCGATCCGTGGAGAGAAGCACTTTAGTTTCGGCCTTTACTTGCAAAGGCT 
197 GCGATCCGTGGAGAGAAGCACTTTAGTTTCGGCCTTTACGTGCAAAGGCT 
Spo 
X 
033 GGATTCGCCAAGCTTTTTTACAGCGCGTCCTAAGTCCGTCGAGCGCCAAT 
197 GGATTCGCCAAACTTTTTTACAGCGCGTCCTAAGTCCGTCGAGCGCCAAT 
Spo 
033 AGAAGCGAGACGCTTTAGTTACCCGAGTGGACCCTTAGCGAGCGAACGCG 
19 7 AGAAGCGAGACGCTTTAGTTACCCGAGTGGACCCTTAGCGAGCGAACGCG 
Spo 
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033 CTTTCGTTTTCTGCTTTGTCAGAAAGACCAAGCTGCAAGGTTCTGTCCCA 
197 CTTTCGTTTTCTGCTTTGTCAGAAAGATCAAGCTGCAAGGTTCTGTCCCA 
Spo 
X 
033 GCTTTGGGACAGAACCTTATATCGAATTCACATTAAGCATACGTTTTTCT 
197 GTTTTGGGACAGAACCTTATATCGAATTCACATTAAGCATACGTTTTTCT 
Spo 
033 TCCGAAACCTTTTCCTAAATCAAATCGTATCCTAGCGTCCAAACAAACTT 
197 TCCGAAACCTTTTCCTAAATCAAATCGTATCCTAGCGTCCAAACAAACTT 
Spo 
033 CGAAGTTGAATTGATTTCAAATATTAAGAATCTATCTTAAGAACCTTAAG 
197 CGAAGTTGAATTGATTTCAJVATATTAAGAATCTATCTTAAGAACCTTAAG 
Spo 
033 AAAAACTAATTACAATCATTCTATAAGTTCGTAATAAAATGTAATCTGAA 
197 AAAAACTAATTACAATCATTCTATAAGTTCGTAATAAAATGTAATCTGAA 
Spo 
033 ATTTCGGAACAAACGCTCAGTATACACAAACGTTCCTTTCAAGGATTCAT 
197 ATTTCGGAACAAACGCTCAGTATACACAAACGTTCCTTTCAAGGATTCAT 
Spo 
033 TCAATCGAACAACTTACTCCAACTTTTTTATCGAACATATGTTTTAGTGT 
197 TCAATCGAACAACTTACTCCAACTTTTTTATCGAACATATGTTTTAGTGT 
Spo 
033 CGCATTTGATTCGCATTCTCGTCAAACTTCAATATACATTTCACCAAACG 
197 CGCATTTGATTCGCATTCTCGTCAAACTTCAATATACATTTCACCAAACG 
Spo 
033 ACACTTAAGCGACAAGAATTACGCCCTTGAAACATTTTTTTATAAAATAT 
197 ACACTTAAGCGACAAGAATTACGCCCTTGAAACATTTTTTTATAAAATAT 
Spo CCCTGGAA-C - - TTTTTTATAAAATAT 
033 TATTATTCTTTTTCAGGTCGTGTATAATAAGGACGTTCATAAAAAGGAAT 
197 TATTATTCTTTTTCAGGTCGTGTATAATAAGGACGTTCATAAAAAGGAAT 
*••*•**•*•* ***** ************* ***************** ** ** 
> < 
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033 GGAGATAAATTATGAAAACAAAGCGAAATGTCTTCCCCGAAAAAGTCAGA 
197 GGAGATAAATTATGAAAACAAAGCGAAATGTCTTCCCCGAAAAAGTCAGA 
Spo GGAGATAAATTATGAAAAPAAAGrGAAATGTrTTrrCrGAAAAAGTrAGA 
033 AAAAAATCAAAGAGACAGACAAATTCAATATTTATTATATGTTGTAGTCT 
197 AAAAAATCAAAGAGACAGACAAATTCAATATTTATTATATGTTGTAGTCT 
Spo AAAAAATrAAAGAGArAOArAAATTrAATATTTATTATATGTTGTAGTrT 
033 CTTCTTATTTTTTACCTCACGTTGTTTACCTGATAAACA?VACTTCTTATG 
197 CTTCTTATTTTTTACCTCACGCTGTTTACCTGATAAACAAACTTCTTATG 
Spo rTTrTTATTTTTTACCTrArGTTGTTTACGTGATAAACAAArTTrTTATG 
ie  ie  i fk  ir  i t  *  ie ie  ic  ic  *  * ie -k ie  ip ie  ie  ie  ie  ir ic  -x ic  ic  -ie ic  -k "k ir  -k *  -k "k ir  ir  ic  ie  ie  ic  ie  "ie -k  i t  ie  ic  "k 
033 CTGATTTACTTAAGCTTTTGCTCCTTATTTCGAATAACAGAAGCGTAAG 
197 CTGATTTACTTAAGCTTTTGCTCCTTATTTCGAATAACAGAAGCGTAAG 
Spo rTGATTTArTTAAGrTTTTGrTrrTTATTTCGAATAACAGAAGrGTAAG 
•kirki t 'k i t ir ir 'kir i tki t iFit 'k ie 'kkkki t ieie 'ki t i t ie^ 'kie 'k 'k 'k 'k 'kkicic 'k 'kie 'k 'k 'kie 'k 'k 'k  
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Figure 3.7: Comparison of L. borgpetersenii serovar hardjo strains by DNA 
hybridization with a sphB probe. DNA was digested with £coRI, 
separated by agarose gel electrophoresis, and transferred to Hybond-N as 
described in the text. The blot was hybridized with [a^^P]pSS 17H1. Lane 
1, strain 117; Lane 2, strain 203; Lane 3, strain Sponselee; Lane 4, strain 
005; Lane 5, strain 113; Lane 6, strain 045; Lane 7, strain 197; Lane 8, 
strainl45. Kb is the kilobase marker. 
Kb 
2036 — 
1636 — 
1018 — 
506 — 
517 
./iVyjRI ./uy^RI ./it'oRI 
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Figure 3.8: Schematic representation of pSS 17H1 containing ORF spliB plus additional sequence from strain Sponselee, (2742 
bp). New sequence upstream o(sphli was obtained as described in the text and is shown as a forward diagonally 
hatched arrow. The region of 11 tandem repeats of 45 bp each are shown with a reverse diagonally hatched arrow. 
Primers 1, left arrow, and 3, right arrow, flank the region of repeat elements as described in the text. The EcoRl 
sites within pSS17Hl are also indicated. 
Figure 3.9: Comparison of PGR products from strains of L. borgpetersenii serovar hardjo 
by restriction endonuclease digestion with HaeUl. (top) Schematic of the 
predicted HaeUl digestions sites for PGR product using primers I and 3 with 
L. borgpetersenii serovar hardjo. Primer 1 is shown as a forward arrow and 
primer 3 as a reverse arrow. HaeYQ. digestion sites are indicated. 
(bottom) HaeUl digestion of PGR products (primers 1 and 3) for strains 
representing RFLPs of sphB in L. borgpetersenii serovar hardjo. 
Lane 1, Bp marker; Lane 2, blank; Lane 3 strain 117; Lane 4, strain 203; Lane 
5, strain Sponselee; Lane 6, strain 005; Lane 7, strain 045; Lane 8, strain 300; 
Lane 9, strain 085; Lane 10, strain 197; Lane 11, strain 145; Lane 12, Bp 
marker. Bp values are shown to the left and right of the figure. 
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Figure 3.10: Comparison of PCR products from strains of L. borgpetersenii serovar 
hardjo by restriction endonuclease digestion with HpdO.. 
top: Schematic of the predicted HpaYi digestions sites for PCR 
product using primers 1 and 3 with L. borgpetersenii 
serovar hardjo. Primer I is shown as a forward arrow and 
primer 3 as a reverse arrow. HpaH digestion sites are 
indicated. 
bottom: HpaR digestion of PCR amplicons (primers 1 and 3) for 
isolates representing RFLPs of sphB in L. borgpetersenii 
serovar hardjo. 
Lane I, Bp marker; Lane 2, blank; Lane 3, strain 117; Lane 4, 
strain 203; Lane 5, strain Sponselee; Lane 6, strain 005; 
Lane 7, strain 045; Lane 8, strain 300; Lane 9, strain 085; 
Lane 10, strain 197; Lane 11, 145. Bp values are shown to 
the left and right of the figure. 
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Hpall 
Hpall 
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(773 bps) 
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Figs. 3.9 for HaeUi and 3.10 for Hpall. Digestion products shown for strain Sponselee agree 
with those predicted. As can be seen from the predicted HaelVL digest and the patterns 
produced, the area of polymorphism involved the fragment containing the region of repeating 
sequence. The HpdH digestion products revealed an additional difference. The repeat unit is 
represented by the smaller of the three bands in each pattern. The size of the individual 
repeating unit was smaller for isolates 300, 085, and 197. Strain 113 also had a smaller size 
(data not shown). These isolates have ail been classified as type B isolates using REA (143). 
Based on these results, the polymorphisms detected in this region oisphB were characterized 
further. 
(v) PCR cloning and sequence analysis. To further characterize the differences in 
the region of repeats, PCR products were prepared using primers 1 and 3 (Table 3.2) for each 
of the representative isolates. These PCR products were cloned and sequenced. Sequence 
analysis indicated that the polymorphisms were due to differing numbers of 45 bp repeat 
elements for type A isolates, while in the type B isolates the region of repeating sequences 
was found to be comprised of a single 45 bp repeat element followed by differing numbers of 
a 30 bp element (Figs. 3.11, 3.12). The 30 bp element is homologous to the 45 bp element 
less the initial 15 bp. The elements are shown in more detail in Fig. 3.13. 
\ putative protein sequence was determined for SphB. The sequence was based on 
Seger's reported sequence (128). additional sequence provided fox sphB by Segers, and the 
remaining sequence oisphB obtained in these studies. This putative protein sequence was 
analyzed for the presence of transmembrane segments by TMPred (117). The results of this 
analysis are summarized in Table 3.3. The strongly preferred orientation for the 
transmembrane region from amino acids 19-39 is from in to out, orienting the region of 
Figure 3.11: Sequence alignment of PGR products from strains representing RFLPs 
detected in sphB of L. borgpetersenii serovar hardjo using primers 1 and 3. 
Identical bases are indicated beneath the sequence by *. Gaps have been 
inserted within the sequence to maintain alignment and are shown as -. 
Strains sequenced were strain 117, strain 203, strain Sponselee (Spo), 
strain 005, strain 045, strain 113, strain 085, strain 197, and strain 145. 
Sequences were aligned using GLUSTAL X (1.5b). 
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117 TACCTCACGTTGTTTACCTGATAAACAAACTTCTTATGCTGATTTACTTAAGCTT 
203 TACCTCACGTTGTTTACCTGATAAACAAACTTCTTATGCTGA.TTTACTTAAGCTT 
Spo TACCTCACGTTGTTTACCTGATAAACAAACTTCTTATGCTGATTTACTTAAGCTT 
005 TACCTCACGTTGTTTACCTGATAAACAAACTTCTTATGCTGATTTACTTAAGCTT 
045 TACCTCACGTTGTTTACCTGATAAACAAACTTCTTATGCTGATTTACTTAAGCTT 
113 TACCTCACGTTGTTTACCTGATAAACAAACTTCTTATGCTGATTTACTTAAGCTT 
085 TACCTCACGTTGTTTACCTGATAAACAAACTTCTTATGCTGATTTACTTAAGCTT 
197 TACCTCACGTTGTTTACCTGATAAACAAACTTCTTATGCTGATTTACTTAAGCTT 
145 TACCTCACGTTGTTTACCTGATAAACAAACTTCTTATGCTGATTTACTTAAGCTT 
117 TTGCTCCTTATTTCGAATAACAGAAGCGTAAGCGACGAAAGTCAGAGTTCAACAG 
203 TTGCTCCTTATTTCGAATAACAGAAGCGTAAGCGACGAAAGTCAGAGTTCAACAG 
Spo TTGCTCCTTATTTCGAATAACAGAAGCGTAAGCGACGAAAGTCAGAGTTCAACAG 
005 TTGCTCCTTATTTCGAATAACAGAAGCGTAAGCGACGAAAGTCAGAGTTCAACAG 
045 TTGCTCCTTATTTCGAATAACAGAAGCGTAAGCGACGAAAGTCAGAGTTCAACAG 
113 TTGCTCCTTATTTCGAATAACAGAAGCGTAAGCGACGAAAGTCAGAGTTCAACAG 
085 TTGCTCCTTATTTCGAATAACAGAAGCGTAAGCGACGAAAGTCAGAGTTCAACAG 
197 TTGCTCCTTATTTCGAATAACAGAAGCGTAAGCGACGAAAGTCAGAGTTCAACAG 
145 TTGCTCCTTATTTCGAATAACAGAAGCGTAAGCGACGAAAGTCAGAGTTCAACAG 
117 GTTACGATCCAATAAGCTCTGGTCCTGCAAGTCCTACCTCACCAGCAGGCCCAGG 
203 GTTACGATCCAATAAGCTCTGGTCCTGCAAGTCCTACCTCACCAGCAGGCCCAGG 
Spo GTTACGATCCAATAAGCTCTGGTCCTGCAAGTCCTACCTCACCAGCAGGCCCAGG 
005 GTTACGATCCAATAAGCTCTGGTCCTGCAAGTCCTACCTCACCAGCAGGCCCAGG 
045 GTTACGATCCAATAAGCTCTGGTCCTGCAAGTCCTACCTCACCAGCAGGCCCAGG 
113 GTTACGATCCAATAAGCTCTGGTCCTGCAAGTCCTACCTCACCAGCAGGCCCAGG 
085 GTTACGATCCAATAAGCTCTGGTCCTGCAAGTCCTACCTCACCAGCAGGCCCAGG 
197 GTTACGATCCAATAAGCTCTGGTCCTGCAAGTCCTACCTCACCAGCAGGCCCAGG 
145 GTTACGATCCAATAAGCTCTGGTCCTGCAAGTCCTACCTCACCAGCAGGCCCAGG 
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117 TCCAGGAGATCTCGACCCATCAAACCCTGACACAGCAAACTCAAGTTCAACAAGT 
203 TCCAGGAGATCTCGACCCATCAAACCCTGACACAGCAAACTCAAGTTCAACAAGT 
Spo TCCAGGAGATCTCGACCCATCAAACCCTGACACAGCAAACTCAAGTTCAACAAGT 
005 TCCAGGAGATCTCGACCCATCAAACCCTGACACAGCAAA.CTCAAGTTCAACAAGT 
045 TCCAGGAGATCTCGACCCATCAAACCCTGACACAGCAAACTCAAGTTCAACAAGT 
113 TCCAGGAGATCTCGACCCATCAAACCCTGACACAGCAAACTCAAGTTCAACAAAT 
085 TCCAGGAGATCTCGACCCATCAAACCCTGACACAGCAAACTCAAGTTCAACAAAT 
197 TCCAGGAGATCTCGACCCATCAAACCCTGACACAGCAAACTCAAGTTCAACAAAT 
145 TCCAGGAGATCTCGACCCATCAAA.CCCTGACACAGCAAA.CTCAAGTTCAACAAGT 
******************************************************** 
117 TCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAG 
203 TCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAG 
Spo TCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAG 
005 TCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAG 
045 TCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAG 
113 TCCGGTTCAG CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
085 TCCGGTTCAG CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
197 TCCGGTTCAG CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
145 TCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAG 
117 CAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAACTCTGA 
203 CAAACCCTGACACAGCAAA.CTCAAGTTCAACAAGTTCCGGTTCAGCAAA.CCCTGA 
Spo CAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGA 
005 CAAACCCTGACACAGCAAACTCAAGTTCAA.CAAGTTCCGGTTCAGCAAACCCTGA 
045 CAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGA 
113 CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
085 CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
197 CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
145 CAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGA 
Figure 3.11 (Continued) 
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117 CACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGACACAGCAAAC 
203 CACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGACACAGCAAAC 
Spo CACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGACACAGCAAAC 
005 CACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGACACAGCAAAC 
045 CACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGACACAGCAAAC 
113 CAAACTCAAGTTCAACAAGTTCCGGTTCAG CAAAC 
085 CAAACTCAAGTTCAACAAGTTCCGGTTCAG CAAAC 
197 CAAACTCAAGTTCAACAAGTTCCGGTTCAG CAAAC 
145 CACAGCAAACTCAAGTTCAACAAATTCCGGTTCAGCAAACCCTGACACAGCAAAC 
117 TCAAGTTCAACAAATTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAA 
203 TCAAGTTCAACAAATTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAA 
Spo TCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAA 
005 CCAAGTTCAACAAATTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAA 
045 TCAAGTTCAACAAATTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAA 
113 TCAAGTTCAACAAGTTCCGGTTCAG CAAACTCAAGTTCAA 
085 TCAAGTTCAACAAGTTCCGGTTCAG CAAACTCAAGTTCAA 
197 TCAAGTTCAACAAGTTCCGGTTCAG CAAACTCAAGTTCAA 
145 TCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAA 
* * * * * * * * * * * * *  * * * * * * * * * * *  * * * * * * * * * * * * * * *  
117 CAAGTTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAATTCCGG 
203 CAAGTTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAATTCCGG 
Spo CAAGTTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGG 
005 CAAGTTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAATTCCGG 
045 CAAGTTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAATTCCGG 
113 CAAGTTCCGGTTCAG CAAACTCAAGTTCAACAAGTTCCGG 
085 CAAGTTCCGGTTCAG CAAACTCAAGTTCAACAAGTTCCGG 
197 CAAGTTCCGGTTCAG CAAACTCAAGTTCAACAAGTTCCGG 
145 CAAATTCCGGTTCAG 
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117 TTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAAC 
203 TTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAAC 
Spo TTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAAC 
005 TTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAAC 
045 TTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAG 
113 TTCAG CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
085 TTCAG CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
197 TTCAG CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
145 
117 CCTGACACAGCAAACTCAAGTTCAACAAATTCCGGTTCAGCAAACCCTGACACAG 
203 CCTGACACAGCAAACTCAAGTTCAACAAATTCCGGTTCAGCAAACCCTGACACAG 
Spo CCTGACACAGCAAACTCAAGTTCAACAAATTCCGGTTCAGCAAACCCTGACACAG 
005 CCTGACACAGCAAACTCAAGTTCAACAAATTCCGGTTCAGCAAACCCTGACACAG 
045 
113 CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
085 CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
197 CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
145 
117 CAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAG 
203 CAAACTCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAG 
Spo CAAA.CTCAAGTTCAACAAGTTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAG 
005 CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
045 
113 CAAA.CTCAAGTTCAACAAGTTCCGGTTCAG CAAACTCAAG 
085 CAAACTCAAGTTCAACAAGTTCCGGTTCAG 
197 
145 
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117 TTCAACAAGTTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAAT 
203 TTCAACAAATTCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGT 
Spo TTCAACAAATTCCGGTTCAG 
005 
045 
113 TTCAACAAGTTCCGGTTCAG 
085 
197 
145 
117 TCCGGTTCAGCAAACCCTGACACAGCAAACTCAAGTTCAACAAGTTCCGGTTCAG 
203 TCCGGTTCAG 
Spo 
005 
045 
113 
085 
197 
145 
117 CAAACTCAAGTTCAAAAGCACCTCCAGGCCGACCAGCAAGTATCGGTATAGGAAG 
203 CAAACTCAAGTTCAAAAGCACCTCCAGGCCGACCAGCAAGTATCGGTATAGGAAG 
Spo CAAACTCAAGTTCAAAAGCACCTCCAGGCCGACCAGCAAGTATCGGTATAGGAAG 
005 CAAACTCAAGTTCAAAAGCACCTCCAGGCCGACCAGCAAGTATCGGTATAGGAAG 
045 CAAACTCAAGTTCAAAAGCACCTCCAGGCCGACCAGCAAGTATCGGTATAGGAAG 
113 CAAACTCAAGTTCAAAAGCACCTCCAGGCCGACCAGCAAGTATCGGTATAGGAAG 
085 CAAACTCAAGTTCAAAAGCACCTCCAGGCCGACCAGCAAGTATCGGTATAGGAAG 
197 CAAACTCAAGTTCAAAAGCACCTCCAGGCCGACCAGCAAGTATCGGTATAGGAAG 
145 CAAACTCAAGTTCAAAAGCACCTCCAGGCCGACCAGCAAGTATCGGTATAGGAAG 
Figure 3.11 (Continued) 
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117 TTCTAGCATAGTAATAACCTACATTCCACCAAACACTG 
203 TTCTAGCATAGTAATAACCTACATTCCACCAAACACTG 
Spo TTCTAGCATAGTAATAACCTACATTCCACCAAACACTG 
005 TTCTAGCATAGTAATAACCTACATTCCACCAAACACTG 
045 TTCTAGCATAGTAATAACCTACATTCCACCAAACACTG 
113 TTCTAGCATAGTAATAACCTACATTCCACCAAACACTG 
085 TTCTAGCATAGTAATAACCTACATTCCACCAAACACTG 
197 TTCTAGCATAGTAATAACCTACATTCCACCAAACACTG 
145 TTCTAGCATAGTAATAACCTACATTCCACCAAACACTG 
Figure 3.11 (Continued) 
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Figure 3.12: Schematic representations of the RPLPs found in the region of tandem repeats 
in sp/iB showing representative strains of L. borgpetersenii serovar hardjo. 
Primers 1 (forward arrow) and 3 (reverse arrow) are indicated. The 45 bp 
element is shown as a solid rectangle and the 30 bp element is shown as a 
forward diagonal rectangle. Strains depicted are strain 117, strain 203, strain 
Sponselee, strain 005, strain 113, strain 045, strain 085, strain 197, and strain 
145. 
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I C A 
45bp C A A  A C C  CTG ACA CAG C A A  A C T  CAA GTT CAA CAA GTT CCG GTT CAG 
30bp CAA ACT CAA GTT CAA CAA GTT CCG GTT CAG 
Ser A5n 
45bp Ala-Asii-Pro-Asp-Thr-Ala-Asn-Ser-Ser-Ser-Thr-Ser-Ser-Gly-Ser 
30bp Ala-Asn-Ser-Ser-Ser-Thr-Ser-Ser-Gly-Ser 
Figure 3.13: Nucleotide sequence and proposed amino acid sequence of 45 bp and 30 bp 
repeat elements from sphB in L. borgpetersenii serovar hardjo. Sequence in 
bold represents sequence missing from the 30 bp repeat element. Underlined 
sequence indicates variable bases and amino acids in the 45 bp repeat element 
68 
TABLE 3.3. Predicted transmembrane segments for SphB using TMpred. 
T ransmembrane 
Propensity 
AA 
position*" out to in in to out Preference Sequence 
19-38 1478 QTNSIFnCCSLFLFFSRCL 
19-39 1817 ft QTNSIFIICCSLFLFFSRCLP 
269-289 861 PGRPASIGIGSSSIVITYIPP 
272-292 1018 t PASIGIGSSSIVITYIPPNTG 
300-320 514 PASTGIGSITSIVETIGSVSV 
298-320 618 t PSPASTGIGSITSIVETIGSVSV 
702-722 847 AYLNYFWNWWYSGGFSGGNGN 
706-727 925 YFWNWWYSGGFSGGNGNYGYYP 
772-794 528 ft KGAWSQYLFLWSNGWRETTFYL 
•'Transmembrane propensity was determined by the TMpred computer program, and a 
value above 500 is a significant indicator of a potential transmembrane-
spanning domain (117). 
''Amino acid position in strain Sponselee. 
tindicates a preference for this orientation. 
ttlndicates a strong preference for this orientation. 
Repeat region in strain Sponselee is from AA 96-260. 
repeats to the outside of the membrane. The predicted protein sequence for SphB (Fig. 3.14) 
was examined for the presence of a signal sequence using SignalP (111). The proposed 
signal sequence represents 4,700 Da, which if cleaved would reduce the size of the mature 
protein from 87.1 kDa to 82.4 kDa. 
Evaluation of protein expression, (i) In vitro translation. In vitro translation was 
performed to determine expression of labeled proteins consistent with the size predicted by 
sequence analysis of sphA and sphB. Results of the in vitro translation reactions are shown 
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T 
1 mktkrmvfpf-kvrk-ksk-rntnt.qtfttrrc^t.pt.fftsrct.pnknt.qyam.t.kt.t.t.t.tsnnr 
61 SVSDESQSSTGYDPISSGPASPTSPAGPGPGDIiDPSNPDTANSSSTSSGSANPDTANSSS 
121 TSSGSANPDTANSSSTSSGSANPDTANSSSTSSGSANPDTANSSSTSSGSANPDTANSSS 
181 TSSGSANPDTANSSSTSSGSANPDTANSSSTSSGSANPDTANSSSTNSGSANPDTANSSS 
241 TSSGSANPDTANSSSTNSGSANSSSKAPPGRPASIGIGSSSIVITYIPPNTGTTNSRPSP 
301 ASTGIGSITSIVETIGSVSVPSGSSRVHFNSQNLEIKILSHNVSLMSTQLPAWANWGQKE 
361 RAEQIANSDYIKHQDIIVFEGLSDANARKILLDGIRSQYPYQTEAVGSTRNGWNATLGVY 
421 RQSTSADGGWIVSQWP lEEKVQYIFDNPGCGVESSYHKGFNYVRINKNGKKFHVIGTQV 
481 QMVGPACSDLGRSVRMNQFNNIKDFIDTKAIPRDELVLIAGDLNVTRGSDEYYGMLTSLN 
541 VSEPKYAGIPYTQDPQVNALTALRHRDSQPTYTNYVLVSKSHSQPEVWQNLAYDPISPKI 
601 WKRSNGHISYEFSDSYPVYGFVYADDTTPTKSGHRRKYDQVSLVSVATGKRIQANSRKKN 
661 GWLKA^JATTETKFTQFNLVQPSDPNSNPFCMESGYVRVEPSAYLNYFWNWWYSGGFSGGN 
721 GNYGYYPKFDDGSNRLQIINLDGGCMQDGSRITFKDYNTVLAKHQYLTIWRKGAWSQYLF 
781 LWSNGWRETTFYLRLNSTPVRDWRSDLIYR 
Figure 3.14: Proposed amino acid sequence of SphB from L. borgpetersenii serovar hardjo 
(strain Sponselee). Underlined sequence indicates putative signal peptide 
predicted by Signal? (111). Arrow indicates proposed signal cleavage site. 
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in Fig. 3.15. Labeled protein bands are visible in both vector and construct reactions. Four 
unique bands are visible for pXlSl: a doublet at 60 to 62 kDa, likely representing the full-
length SphA protein; weak bands at 33 and 40 kDa; and a strong band at 30 kDa. Multiple 
unique protein bands are visible for p2728B: a strong 103 kDa band; a weak band at 92 kDa 
and a broad 76.3 to 82.4 kDa band, which may represent the expected 87.1 kDa sphB 
product; and a band from 65.8 to 72.6 kDa. Below these bands appears a doublet of 57-59.8 
kDa and finally just above the bands in common with pCR2.1 is a weak band at 39.8 kDa. 
Hemolytic activity of unlabeled sphB gene product was not detected (data not shown). 
(ii) RT-PCR and analysis of leptospiral expression of sphA and sphB. To 
determine if sphA or sphB were transcribed during growth under culture conditions, positive 
controls using purified leptospiral DNA in PCR were compared with amplified cDNA from 
RT-PCR. Products of the sizes predicted iov sphA (448 bp) and sphB (230 bp) (Fig. 3.16) are 
visible for the three isolates evaluated—Sponselee, 197 (Clone JB), and 033 (Clone RZ33) in 
both the positive and RT containing lanes. Negative RT-PCR contols, lacking reverse 
transcriptase, were performed to control for presence of contaminating leptospiral DNA in 
the RNA preparations. These reactions do not show visible amplification products-
Expression oisphA and sphB by serovar hardjo grown in culture was evaluated by 
immunoblotting. An immunoblot of a Triton X-114 outer membrane preparation from 
serovar hardjo (strain Sponselee) was reacted with 1:1,000 anti-GST, 1:1,000 anti-GST and 
1:1,000 anti-GST-SphA, 1:1,000 anti-GST-SphA, 1:1,000 anti-AXH3, and 1:1,000 normal 
rabbit serum. The immunoblot was developed using ECL™ detection reagents and is shown 
in Fig. 3.17. Reactive bands of 45, 43, 40, 33, and 29.5 kDa are unique to anti-GST-SphA. 
A band of 56 kDa and a faint band of 24 kDa are visible in the lane reacted with anti-AXH3. 
Figure 3.15: In vitro coupled transcription-translation of sphingomyelinase encoding 
genes. Plasmid encoded proteins were labeled in vitro with ['"^Cj-Ieucine, 
separated by SDS-PAGE, and then visualized by fluorography. Reaction 
templates were: Lane 1, p2728B (sphB); Lane 2, pCR2.1 (vector); Lane 3, 
pXlSl (sphA); Lane 4, pBCKS- (vector); Lane 5, No DNA. Molecular 
mass markers are shown on the sides in kDa. 
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Figure 3.16: RT-PCR detection of sphA and sphB transcripts in L. borgpetersenii 
serovar hardjo. In Lanes 1-7 primers 34 and 35 were used to detect sphA 
and in Lanes 9—15 primers 35 and 37 were used to detect sphB. Lanes 1 
and 9 are positive control PCR reactions using genomic DNA from strain 
Sponselee and primers 34 and 35, and primers 36 and 37 respectively. 
RT-PCR reaction products are shown in Lanes 2-7 and Lanes 10-15. The 
symbol + indicates reverse transcriptase was added to the reaction and -
indicates no reverse transcriptase was added. Lanes 2, 3, 9, and 11, strain 
Sponselee; Lanes 4, 5, 12, and 13, strain 033; Lanes 6, 7, 14, and 15, strain 
197. Size markers are shown to the left of the figure. 
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Figure 3.17: Immunoblot of Triton X-114 preparation of L horgpetersenii serovar hardjo (strain Sponselee). Triton X-114 
preparation was separated by SDA-PAGE, blotted to Immobilon''''^-P, exposed to different antisera and developed 
using ECL detection reagents. The autoradiogram is shown. Lanes represent different antisera diluted 1:1,000: 
Lane 1, anti-GST; Lane 2, anti-GST and anti-GST-SphA; Lane 3, anti-GST-SphA; Lane 4, anti-AXH3; Lane 5, 
normal rabbit serum. Arrow indicates faint 24 kDa band described in the text. Molecular mass markers are shown 
on the sides in kDa. 
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DISCUSSION 
In the present study, we characterized two putative L. borgpetersenii virulence genes, 
spliA and sphB, and described genetic variability within each gene based on hybridization and 
sequence analysis. This genetic variability may help to explain the phenotypic differences 
between serovar hardjo isolates, particularly in relationship to the ability of isolates to cause 
disease. Experimental evidence showing that the gene products o^sphA and sphB are 
expressed during growth in culture and are localized in the outer membrane is presented. 
Presence of these putative virulence determinants in the outer membrane may be important in 
host-pathogen interactions. 
SphA was originally identified in a serovar hardjo isolate and was cloned and 
sequenced by Segers et al. (128). The cloned protein demonstrated hemolytic activity when 
expressed in £. coli. In this study, two polymorphisms were detected in the region upstream 
of sphA. One of these polymorphisms was represented by 199 of the 200 serovar hardjo 
isolates examined, with the variant represented by a single isolate. Sequence analysis of the 
polymorphic region firom representative isolates of serovar hardjo and the variant strain 
(strain 005), demonstrated the presence of a sequence homologous to previously described 
insertion sequence (IS) elements in Leptospira. Specifically, the polymorphic region 
contained sequence that was highly homologous to IS 1501 (GENBANK accession 
#AF038931 and #AF038932) (162) and to ORF B of IS 1500 (22). IS elements in Leptospira 
are believed to transpose (22), which could account for the presence of this sequence and 
creation of this RFLP. Further upstream sequence would be required to determine if a 
complete IS element is present at this site. It is apparent that transposition of an IS element 
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to this site may be a rare event, as only a single variation present in only one isolate was 
detected among the 200 isolates studied. 
The isolate of serovar hardjo containing the polymorphism in spliA was isolated in 
1974 from a bovine kidney collected at a slaughterhouse in Illinois. This isolate had 
undergone a number of in vitro passages prior to the preparation of the DNA analyzed in this 
study. It is possible that the polymorphism detected occurred during growth in vitro rather 
than in vivo. Multiple DNA preparations from this organism demonstrated the same 
polymorphism indicating that the change is stable in the laboratory. The stability of the 
polymorphism in vivo was not determined, and the biological significance of the change is 
unknown. 
SphB was identified by Segers et al in the genome of serovar hardjo by DNA 
homology studies using sphA as probe (127). The fragment identified by Segers et al 
contained a partial ORF with homology to sphA and was designated sphB. In this study, the 
entire gene, including ORF and upstream sequence sequences were identified and 
characterized. Sequence upstream of sphB contains regions of sequence similar to those 
described for sphA and may represent regulatory elements (128). 
In this study, multiple polymorphisms were detected in the ORF o^sphB among 
serovar hardjo isolates from around the world. The polymorphisms consisted of tandemly 
repeated elements assembled in two different patterns. In one group of isolates, the 
polymorphisms detected were due to differing numbers of a 45 bp element tandemly 
repeated. In another group of isolates, the polymorphic regions contained a single copy of 
the 45 bp element followed by differing numbers of a 30 bp element. The 30 bp element was 
found to be highly homologous to the 45 bp element with the deletion of the initial 15 bp. 
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It is possible that both the variable number of repeats and the loss of 15 bp from the 
45 bp repeat are due to slipped strand mispairing (4,148) as shown in Fig. 3.18. Conversion 
of the sequence CAAACCC to CAAACTC, as is seen in the sequence obtained from isolate 
117, would allow slippage. This could result in the loss of the 15 bp region separating these 
two regions. The 45 bp repeat 
rr A A ACTrTGAC ACAGC A A ACTCAAGTTCAACAAATTCCGGTTC AG) was probably 
converted to the 30 bp repeat unit (CAAACICAAGTTCAACAAGTTCCGGTTCAG) by 
deletion. Removal of 15 bp from the 45 bp repeat would prevent reversion from the 30 bp 
repeat to the 45 bp repeat. It does appear that maintenance of a single 45 bp is either 
necessary to the protein or that a single copy of the 45 bp repeat becomes fixed after the 
conversion to the smaller 30 bp unit. The significance of the repeat and its structure is not 
clear. In other organisms, variations in the number of repeats within a molecule have been 
implicated in alteration of antigenicity and escape from host immune response (65. 87, 101). 
Genetic variations previously identified by REA using the enzyme Hhal separate L. 
horgpeiersenii serovar hardjo isolates into two major groups, type A and type B . Likewise, 
IS 1533-based typing shows a similar split between type A and type B isolates. Interestingly, 
the polymorphic region of sphB from each of the six REA type A isolates sequenced in this 
study had tandem repeats of the 45 bp element; whereas the three REA type B isolates 
sequenced contained a single 45 bp sequence and different numbers of the 30 bp element. 
However, the Hhal digestion fragments, which contain sphA or sphB (data not shown) are not 
the ones that vary between REA type A and t>pe B isolates. Therefore, the polymorphisms 
detected in sphB are not responsible for the REA pattems seen. 
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(a) (b) 
+ + 
Figure 3.18. Schematic of the mechanism of slipped strand mispairing. Deletions and 
amplifications can occur if direct repeats (boxes) on one DNA duplex mispair 
out of register closed to a replication fork, (a) Slippage of a template strand 
and excision of the loop or replication across the resulting loop, followed by 
repair, leads to deletion, (b) Slippage of a strand being synthesized followed 
by repair can yield amplification. The figure and legend were reproduced 
from M. Singer and P. Berg (130). 
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The technique used to screen the 200 serovar hardjo isolates for polymorphisms in 
sphA and sphB was not sufficiently sensitive to detect minor differences. Differences were 
identified on the basis of fragment size, and it is likely that the separation techniques used in 
this study would not demonstrate differences of 30 to 45 bp or less. Isolates representative of 
polymorphisms detected by hybridization with sphB were further characterized by PCR and 
sequence analysis. 
Analysis of RNA from actively growing leptospiral cells by RT-PCR indicates that 
both sphA and sphB are transcribed during growth in culttire. Three different isolates of 
serovar hardjo, the type strain (isolate 033), the strain from which sphA and sphB were 
originally identified (strain Sponselee), and a field isolate of serovar hardjo from the United 
States (strain 197) were evaluated. Transcription of sphA and sphB was detected in each of 
the three isolates examined. 
In vitro reactions were performed to examine gene products of sphA and sphB and to 
evaluate the hemolytic functionality of the sphB gene product. Products detected were in 
close agreement with the predicted molecular mass of 63 kDa for sphA gene product. The 
other products delected may represent internal initiation or premature termination of the 
translation reaction. Product consistent with the predicted molecular mass of sphB gene 
product were not detected in the sphB translation reaction, nor was hemolytic activity 
demonstrated using the sphB gene products. The reasons for these results are unknown but 
may indicate that sphB sequence is unsuitable for use in an E. coli in vitro translation system. 
Immunoblotting of a leptospiral TX-114 outer membrane preparation was used to 
evaluate expression of sphA and sphB in serovar hardjo. Rabbit polyclonal antiserum 
produced against GST-SphA fusion proteins reacted with more than one band in the outer 
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membrane preparation of serovar hardjo by immunoblot. The size of the bands was not 
consistent with the predicted size of the protein (63 kDa) encoded by the ORF sphA, or with 
the size of the product (61 kDa) expected after cleavage of a putative signal peptide. The 
difference between the size of the proteins recognized by the antiserum and the protein size 
predicted on the basis of amino acid sequence could be due to several factors, including post-
translational modifications, protease activity that has been detected in Leptospira (167), or 
the presence of cross-reactive proteins. 
Polyclonal antiserum produced against a portion of SphB (in AXH3) also reacted with 
multiple bands in immunoblots of serovar hardjo outer membranes. The 56 and 24 kDa 
bands, when combined, would yield a protein of 80 kDa, which is close to the 82.4 kDa size 
predicted for SphB after cleavage of a 4.7 kDa signal sequence. 
Based on predicted amino acid sequence and analysis of the sequence for membrane 
spanning regions, the portion of SphB with homology to other sphingomyelinase proteins is 
oriented to the outside of the membrane. While a signal sequence was not detected when the 
sequence of SphB was analyzed by Signal? (Ill) using parameters set for Gram-negative 
organisms, a signal sequence satisfying parameters set for Gram-positive organisms was 
detected. Although SphB has some similarity to proteins in Gram-positive organisms, there 
are a number of differences as well. The carboxy-terminus of SphB contains several charged 
residues, but the net charge is not consistent with the strong positive charge described for 
other Gram-positive surface proteins. In addition, there is no amino acid sequence 
homologous to the LPXTGX sequence described for many of these surface proteins (125). 
Variable regions of sphA and sphB, potential virulence factors for Leptospira, were 
identified in this study. In addition, transcription and translation of the genes was 
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documented for the first time. It is not clear what role, if any, these genes, or the variability 
detected in them, play in the pathogenicity of serovar hardjo isolates for cattle. However, tlie 
results of this study indicate that further characterization of these genes and their products is 
warranted. 
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CHAPTER 4. EVALUATION OF RECOMBINANT PROTEIN 
VACCINES CONTAINING PORTIONS OF SPHA AND SPHB IN 
A HAMSTER MODEL OF L BORGPETERSENIISEROVAR 
HARDJO INFECTION 
A paper to be submitted to Infection and Immunity 
David P. Alt, Ruud P. A. M. Segers, Dean Bamett, Eric KJaasen, Richard L. Zuemer, and 
Carole A. Bolin 
ABSTRACT 
Killed whole-cell leptospiral vaccines fail to protect cattle against infection with 
Leptospira borgpetersenii serovar hardjo. Leptospiral outer membranes, a primary' site for 
host-pathogen interaction, may contain antigens that will provide a protective immune 
response. SphA, a hemolysin with sphingomyelinase activity found in L. borgpetersenii 
serovar hardjo and SphB, a related serovar hardjo protein, are found in outer membrane 
preparations from this organism. Therefore we sought to determine if recombinant SphA and 
SphB proteins could protect hamsters from virulent challenge. Following immunization with 
purified recombinant fusion proteins containing portions of SphA and SphB, hamsters were 
subsequently challenged by intraperitoneal inoculation with a highly virulent isolate of L. 
borgpetersenii serovar hardjo. Vaccines containing portions of either SphA or SphB, or the 
two combined did not prevent or alter the course of serovar hardjo infection in hamsters. In 
contrast, three of three animals given the killed whole-cell bacterin survived until fourteen 
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days after challenge and had no evidence of infection. Thus, the recombinant proteins SphA 
and SphB given singly or in combination did not provide protection equal to that provided by 
a whole-cell bacterin in this study. 
INTRODUCTION 
The most common cause of bovine leptospiral abortion throughout the world is 
infection with serovar hardjo (54, 141, 154). Infection also may result in stillbirths, the birth 
of weak neonates, and may result in decreased milk production with the development of a 
flaccid mastitis (142). Serovar hardjo is comprised of two species of Leptospira: Leptospira 
borgpetersenii serovar hardjo type hardjo-bovis and Leptospira interrogans serovar hardjo 
type hardjoprajimo based on restriction endonuclease analysis (REA) patterns and genetic 
reiatedness studies (155, 159). Leptospira borgpetersenii serovar hardjo type hardjo-bovis 
will hereafter be referred to as type hardjo-bovis, and Leptospira interrogans serovar hardjo 
type hardjoprajitno will be referred to as type hardjoprajimo. 
Cattle are considered to be a maintenance host for both types of serovar hardjo (46) 
and the bovine immune response to infection with these organisms is often minimal. 
Agglutinating antibody titers may be low to undetectable, even in animals from which the 
organism is isolated (46, 142, 160). Infection can lead to localization of the infecting 
organism to the kidney with development of persistent renal shedding (113). This shedding 
has been shown to persist for months experimentally (142), and may be lifelong in naturally 
acquired infections. In addition, other studies have isolated the organism from the pregnant 
uterus (45) and shown persistence of the infection in the tissues of the male (39) and female 
genital tracts (45, 52), as well as the urinary tract (45, 52, 113). These sites of infection raise 
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the possibility of venereal transmission (44) in addition to transmission by contact with 
infectious urine. Organisms also have been demonstrated in vaginal discharges following 
abortion and calving (47) providing another means for transmission of the organism to 
susceptible hosts. 
In cattle, whole-cell bacterins (78,99, 147) and a cell wall vaccine (147) have 
protected against infection with serovar hardjo or decreased the period of leptospiruria (99). 
More recent studies, however, have not been consistent with these findings. In studies using 
pentavalent killed whole-cell vaccines containing type hardjoprajitno (20) and type hardjo-
bovis (21), vaccinated cattle were not protected from infection with type hardjo-bovis; 
vaccinated cattle developed leptospiruria and fetal infection. In addition, transfer of the 
infection to the fetus also was noted (20). An additional study performed using a killed 
monovalent type hardjo-bovis vaccine demonstrated that while vaccination induced 
development of IgG and agglutinating antibodies to lipopolysaccharide (LPS), it failed to 
protect against infection with type hardjo-bovis (18). 
Because traditional whole-cell bacterins fail to protect cattle against this important 
pathogen, alternate approaches are needed for vaccine development. Antigens in the outer 
membrane of Leptospira make attractive candidates for vaccine development. Outer 
membrane proteins have been shown to be differentially expressed in Leptospira depending 
on the growth environment of the organism, in vitro versus in vivo (13, 67, 68). As the site of 
host-pathogen interactions, the outer membrane likely plays an important role in 
development of host inununity and has been shown to be the primary target for 
immunoglobulin-mediated killing of leptospires (7). Proteins localized to the leptospiral 
outer membrane also have been shown to be reactive to hyper-immune rabbit antiserum 
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(112). Therefore, proteins located in the outer membrane may provide more effective targets 
for vaccination against disease. 
In Borrelia burgdorferi, outer membrane proteins OspA and OspB play a role in 
protection of mice from infection (56, 57). In previous experiments using outer membrane or 
outer envelope preparations from leptospires, protection from infection has been 
demonstrated (9, 14, 15, 64). These preparations, however, contained quantities of LPS, as 
well as protein. As previously stated, antibody responses to leptospiral LPS do not correlate 
with protection of cattle against serovar hardjo. 
A gene coding for a hemolysin, sphA, has been identified in serovar hardjo. The 
protein expressed from this gene is cell associated (128), present in outer membrane extracts 
(this study), and has hemolytic and sphingomyelinase activity (128). A related gene, sphB, 
also is found in type hardjo-bovis isolates, is expressed in vitro, and the protein product is 
present in outer membrane extracts (this study). The role of these proteins in the 
pathogenesis of serovar hardjo infection is not clear. 
Hemolysins and sphingomyelinases in other organisms have been shown to play a 
role in virulence and exert effects on eukaryotic cells. In Serpulina hyodysenteriae, tlxA 
mutants are hemolysin-negative and have shown reduced virulence (79). Listeria 
monocytogenes, an intracellular pathogen, requires a pair of phospholipases, plcA and plcB, 
for optimal intracellular growth. BothpicA, a phosphatidylinositol-specific phospholipase C. 
and plcB, a broad spectrum phospholipase C that can hydrolyze sphingomyelin, act 
synergistically. It is proposed that plcA allows escape from the double-membrane-bound 
vacuole encountered during cell to cell spread, while plcB allows escape from the primary 
vacuole encountered on initial infection (132). The beta-toxin of Staphylococcus aureus, a 
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sphingomyelinase, has been shown to be cytocidal and promote cytokine release in human 
monocytes (153). 
Hamsters are used to assess candidate vaccines for protection against highly virulent 
serovars oiLeptospira. Hamster studies for evaluation of serovar hardjo vaccines, however, 
are complicated by the lack of hamster-virulent isolates of serovar hardjo isolates. Recently, 
we identified an isolate of serovar hardjo (strain 197) that is lethal for hamsters. Infection 
with this isolate produced clinical signs of icterus and hemorrhage from the nares and 
urogenital opening with fatal infection occurring within seven days after infection with 10*" 
organisms (unpublished data). Because of the hemolytic lesions seen in hamsters infected 
with strain 197, it is possible that expression of hemolysins, such as SphA or SphB may play 
a role in the virulence of this organism. 
The purpose of this study was to evaluate recombinant proteins, representing portions 
of both SphA and SphB, for their ability to protect hamsters from infection with a clone of Z. 
borgpetersenii serovar hardjo (strain 197). 
MATERIALS AND METHODS 
Reagents. Sea Plaque® agar was obtained from FMC BioProducts (Rockland, Me.). 
PLM5 medium was obtained from Intergen Corp. (Purchase, N.Y.). Immobilon™- P was 
piu^chased from Millipore Corp. (Bedford, Mass.). The ECL™ detection reagents were 
purchased from Amersham Life Science (Arlington Heights, III.). Autoradiography film, 
Biomax MR, was purchased from Kodak (Rochester, N. Y.). Ribi adjuvant (MPL® + TDM, 
R-700 emulsion) was obtained from Ribi Immunochem. Research, Inc. (Hamilton, Mont.). 
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Animals. Weanling, female hamsters, three to four weeks old, used in these studies 
were obtained from Charles River Laboratories (Wilmington, Me.). Hamsters were housed 
in accordance with AAALAC-approved guidelines and were provided food and water ad 
libitum. Animals were sedated for procedures by administering 50 mg/kg ketamine 
combined with 10 mg/kg .xylazine given by the IM route. 
Recombinant proteins and vaccine preparation. Glutathione S-transferase (GST), 
and GST-fusion proteins GST-SphA and GST-SphB were obtained from Dr. Ruud Segers, 
Department of Bacteriological Research, Intervet International B.V. (Boxmeer, The 
Netherlands). These proteins represented fragments of both spliA (128) and sphB (127). An 
additional fusion protein AXH3, containing the same portion oisphB as GST-SphB, also was 
used. In contrast to GST-SphB, this protein was expressed using a different fusion and 
purification method, and the resulting protein, AXH3, contained a smaller fusion segment 
than that found in GST-SphB. Construction of plasmid pAXH3 is described in Chapter 3. 
Recombinant fusion proteins were emulsified with Ribi adjuvant (MPL® TDM, R-
700 emulsion) as recommended by the manufacturer. The emulsions contained 0.25 mg,'ml 
of GST, GST-SphA, or GST-SphB. The combination vaccine GST-SphA/GST-SphB 
contained 0.25 mg/ml of each of the proteins, and vaccine AXH3 contained 0.2375 mg/ml of 
protein AXH3 in the final vaccine preparation. BCilled whole-cell bacterin (batch: BAC-
HP971216) was received from Dr. Segers and was prepared using 10"^ L. interrogans serovar 
hardjo type hardjoprajimo per ml of vaccine. 
Vaccine Groups. Weanling, female hamsters were divided into seven treatment 
groups of 5 animals each. The treatment groups were as follows: Group I-no vaccine 
(infection controls); Group Il-whole-cell bacterin; Group III-GST vaccine (fusion protein 
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control); GroupIV-GST-SphA; Group V-GST-SphB; GroupVI-GST-SphA/GST-SphB; and 
Group Vn-AXH3. Each hamster was given two injections of 0.2 ml emulsion 
subcutaneously, three weeks between injections. The no-vaccine control group was not 
injected. 
Challenge. Hamsters infected with L. borgpetersenii serovar hardjo (strain 197) 
demonstrated clinical signs including icterus and hemorrhage from the nares and urogenital 
opening. At necropsy, hemorrhage in the lung and in other tissues was noted. Plasma was 
obtained from a hamster infected with strain 197. This hamster demonstrated advancing 
clinical signs, and plasma was shown to contain live leptospires by darkfield microscopy. 
Using liquid PLM5 medium, the plasma sample was diluted sufficiently to contain 
approximately 50 colonies in a pour-plate. The pour-plate was prepared by supplementing 
PLM5 medium with 0.8% Sea Plaque® agar. The medium was poured, allowed to solidify, 
and incubated at 29°C until colony growth became visible. A colony, designated Clone JB. 
was picked from this plate, grown in liquid PLM5, and 10*^ organisms were used to infect 
hamsters. Hamsters infected with this clone demonstrated clinical signs, gross lesions, and a 
course of disease consistent with those observed previously with L borgpetersenii serovar 
hardjo strain 197 infection. Challenge material for this study was prepared by mechanically 
disrupting liver tissue obtained from infected hamsters euthanized during the course of 
disease. Infected liver tissue was processed to a slurry in 9 ml of leptospiral transport 
medium (146). The suspension was allowed to settle and supematant was drawn off and 
diluted for counting using a Petroff-Hauser counting chamber. 
Hamsters were challenged two weeks following final vaccination. One ml of liver 
suspension containing lO' leptospires/ml was given by the intraperitoneal route to each 
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sedated hamster. Hamsters were observed three times daily for development of clinical signs 
of leptospirosis. 
One animal from each group was euthanized 3 days post-challenge (PC) and blood 
and liver were collected to detect the presence of leptospires. Because of the rapid course of 
disease progression in the groups receiving recombinant proteins, only animals in the no-
vaccine and bacterin group survived to day 6 PC. On day 6 PC, liver and kidney from one 
animal in the no-vaccine and bacterin groups were examined for the presence of leptospires 
using culture, darkfield, and fluorescent antibody testing. The remaining animals in the no-
vaccine group were euthanized due to progression of clinical signs by day S PC. The three 
animals remaining in the bacterin group were euthanized on day 14 PC. Liver and kidney 
were collected from all animals euthanized after day 3 PC and were processed for culture, 
fluorescent antibody testing, and darkfield examination to detect the presence of leptospires. 
Culture. Tissue specimens (1 g) collected from hamsters were mechanically 
disrupted through a 3 ml syringe into 9 ml transport medium (146). One ml of blood was 
also suspended in 9 ml transport medium. Both suspensions were processed for leptospiral 
culture as described (20). Semisolid culture medium was prepared from PLM5 by addition 
of purified agar (1.5 g/L) and 5-fluorouracil (100 ^ug/ml). Aliquots of the 10 ' and 10"^ 
dilutions of tissue suspensions were inoculated into culture medium, incubated, and 
examined as described (20). 
Fluorescent antibody testing (FAT). Tissue specimens (1 g) were mechanically 
disrupted by passage through a 3 ml syringe into 5 ml of sterile 0.01 M phosphate-buffered 
saline solution (pH 7.2). This suspension and the remaining diluted blood suspension were 
processed, stained with fluorescein-labeled anti-L. borgpetersenii serovar hardjo conjugate. 
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and counterstained with flazo-orange as previously described (118). Leptospires were 
identified on the basis of typical shape and specific fluorescence when viewed under incident 
light microscopy. 
Dot-blot immunoassay. On the day of challenge, hamsters were sedated, and 
periorbital bleeding was performed. Blood collected was allowed to clot and serum was 
harvested. To determine if a humoral response to the recombinant proteins had occurred, 
serum was tested for antibodies against SphA and SphB in a dot-blot immunoassay as 
follows. Four of each preparation, 0.5 mg/ml for GST, GST-SphA, and GST-SphB, 0.475 
mg/ml for protein AXH3, and lO' leptospires/ml for bacterin, was dot-blotted to 
Immobilon™- P, prewet with methanol. The membranes were allowed to dry. Membranes 
were again wet with methanol and blocked at room temperature for I h in 0.01 M PBS, (pH 
7.2), 0.1% Tween 20, and 5% skim milk (blocking buffer). Primary antibody consisted of 
1:500 dilutions of serum, pooled for each vaccine group, and diluted using the blocking 
buffer. The blocked membranes were reacted with the diluted serum for 1 h at room 
temperature. Following this, the membranes were washed briefly 2 times in blocking buffer 
and then 2 times for 15 min each in blocking buffer, and finally 2 times for 5 min each in 
blocking buffer. Secondary antibody consisted of a 1:500 dilution of horseradish peroxidase-
labeled goat anti-hamster IgG, also diluted in blocking buffer. The membranes were allowed 
to react for I h at room temperature. The membranes were again washed twice briefly, then 2 
times for 15 min each, and finally 2 times for 5 min each in 0.0IM PBS. Reactions were 
developed according to manufacturer's directions using the ECL™ kit and exposed to 
autoradiography film, Biomax MR. 
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RESULTS 
Dot-biot assay. The resuhs of the assay are presented in Fig. 4.1. Serum from 
animals given any of the vaccine preparations contained antibodies that reacted with the 
appropriate vaccine antigens by immunoblotting. Hamsters vaccinated with the whole-cell 
bacterin produced antibodies that showed minimal reactivity to the recombinant proteins 
tested, but reacted well with the bacterin preparation itself. There was considerable cross-
reactivity of the antibodies produced by hamsters given the various fusion protein vaccines 
and GST alone. This was expected because of the shared portions of the fusion proteins or 
the inclusion of the same construct of the sphB open reading frame. 
Results of challenge. One animal immunized with GST-SphA and one animal that 
received GST-SphA/GST-SphB were euthanized prior to challenge for reasons unrelated to 
infection. Challenged animals were monitored closely for clinical signs and euthanized when 
evidence of advancing disease severity was clear. 
No-vaccine control hamsters became severely ill 6 to 8 days after challenge with 
serovar hardjo and were euthanized. Serovar hardjo was delected in the tissues of each 
hamster in this group at necropsy. Hamsters given vaccines containing GST, GST-SphA, 
GST-SphB, GST-SphA/GST-SphB, or AXH3 were not protected from infection or disease 
following challenge with serovar hardjo. In contrast, 3 of 3 animals given the whole-cell 
bacterin and followed for 14 days survived challenge with serovar hardjo. In addition, 
leptospires were not detected in their tissues at post-mortem. However, leptospires were 
detected in the tissues of hamsters given the whole-cell bacterin and euthanized 3 and 6 days 
PC (one animal at each timepoint), indicating that protection from challenge was not 
complete. 
Figure 4.1: Dot Blot assay showing hamster antibody response to recombinant protein 
preparations. Antigens: Lane I, GST-SphA; Lane 2, GST-SphB; Lane 3, 
AXH3; Lane 4, Bacterin. Antisera diluted 1:500: Lane 1, No vaccine; 
Lane 2, Bacterin; Lane 3, GST; Lane 4, GST-SphA; Lane 5, GST-SphB; 
Lane 6, GST-SphA and GST-SphB; Lane 7, AXH3; Lane 8, Secondary 
antibody only. 
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DISCUSSION 
Effective vaccines are needed to protect cattle from bovine leptospirosis caused by 
infection with L borgpetersenii serovar hardjo. Ideally, an effective vaccine should prevent 
infection and shedding of serovar hardjo, as well as preventing clinical signs in infected 
cattle. Traditional whole-cell serovar hardjo vaccines have not consistently proven to prevent 
infection, urinary shedding, or reproductive disease in cattle exposed to serovar hardjo. 
Therefore, development of and evaluation of alternative vaccines is needed to provide 
adequate control of bovine leptospirosis. 
Immunoassays using serum collected from immunized hamsters immediately prior to 
challenge indicated that hamsters in each vaccine group, (GST, GST-SphA, GST-SphB. 
GST-SphA/GST-SphB, AXH3, and killed whole-cell bacterin) produced antibody that was 
reactive with the antigen in the relevant vaccine. However, despite the presence of antibody 
against SphA and SphB, immunized hamsters were not protected against infection or disease 
caused by serovar hardjo. A control whole-cell vaccine provided protection against disease, 
but not infection, in this model of serovar hardjo infection. 
Vaccines containing portions of either or both SphA and SphB may have failed to 
protect against infection and disease in this study for several reasons. Hamsters were 
challenged with 10' cells of a highly virulent strain of serovar hardjo, which may represent an 
overwhelming challenge. However, animals immunized with a traditional whole-cell serovar 
hardjo vaccine were partially protected against severe disease resulting from this highly 
virulent challenge, although some hamsters in this group became infected following 
challenge. Use of a less severe challenge might have allowed detection of partial protection 
by the vaccines containing recombinant proteins. 
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Vaccines containing recombinant proteins also may have failed because the 
antibodies induced as a result of vaccination did not react with native protein in vivo. 
Polyclonal rabbit anti-GST-SphA antiserum and polyclonal rabbit anti-AXH3 antiserum 
reacted by immunoblot to proteins in outer membrane preparations of serovar hardjo. 
However, these antibodies failed to cause agglutination of live Leptospira and failed to stain 
intact Leptospira by indirect immunofluorescence or immunohistochemistry (data not 
shown). This lack of reactivity to intact organisms may relate to low expression of SphA or 
SphB on the surface of serovar hardjo or to the specificity of the antibodies induced by 
immunization with the recombinant proteins. Conformational epitopes may be present on the 
intact protein, which may be absent from the recombinant proteins, or these epitopes may be 
altered by presentation as fusion proteins. 
The fusion proteins of SphA and SphB used to immunize hamsters only contained 
portions of the relevant proteins. Both the fusion proteins of SphA and SphB contained the 
regions that share homology with other bacterial sphingomyelinases. In the case of SphB, 
attempts to express sphB with the repeat elements described by Segers (126), were 
unsuccessful (Segers, personal communication). In Borrelia burgdorferi, vaccination of 
mice with full-length OspA provides protection against infection, while vaccination with 
truncated forms of OspA fails to produce protective immunity, despite reactivity of the 
truncated proteins with a protective MAb (16). Bockenstedt et al. concluded that although 
the antibodies produced by vaccination with the truncated OspA bind to full-length OspA in 
immunoblots, they fail to bind to native OspA expressed on the spirochete growing in vivo 
(16). 
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The results of this study do not exclude SphA and SphB as useful components of a 
future leptospiral vaccine. Immunogenicity of full-length SphA and SphB proteins in serovar 
hardjo needs to be more thoroughly investigated. Use of flill-Iength proteins as immunogens 
may be complicated by enzymatic or toxic activities of the proteins. Production of 
recombinant full-length proteins may require the use of alternative expression vectors or use 
of different organisms for expression. Attempts to express full-length sphB have not been 
successful. 
This study describes the development of a lab animal model of serovar hardjo 
infection that produces a fatal hemorrhagic form of leptospirosis. The disease seen in 
hamsters infected with serovar hardjo strain 197 in this study is similar to acute leptospirosis 
in hamsters induced by infection with other serovars of Leptospira. To date, other strains of 
serovar hardjo that are reliably virulent for hamsters have not been described, although some 
isolates show virulence transiently after isolation. The findings presented here document the 
virulence of this isolate of serovar hardjo for hamsters. This suggests that isolates of serovar 
hardjo may differ in virulence for hamsters. Serovar hardjo isolates from different parts of 
the world differ in their pathogenicity for cattle as well, and this indicates the need to use 
thoroughly characterized local isolates for vaccine efficacy trials in laboratory animals and 
cattle. 
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CHAPTER 5: GENERAL DISCUSSION 
The studies presented here further characterize two putative Leptospira 
borgpetersenii serovar hardjo sphingomyelinase genes, sphA and sphB. Isolates (n=200) of 
L. borgpetersenii serovar hardjo were examined for variability in these genes. Transcription 
of sphA and sphB was determined in culture-grown organisms and reactive proteins were 
demonstrated in outer membrane preparations using rabbit polyclonal antiserums raised 
against fusion proteins of both SphA and SphB. In addition, fusion proteins of SphA and 
SphB were evaluated as altemative vaccines using a hamster model of serovar hardjo 
infection. Vaccination with either or both SphA or SphB failed to protect hamsters from 
infection or disease induced by challenge with a highly virulent strain of serovar hardjo. 
Sphingomyelinase genes present in L. borgpetersenii serovar hardjo are 
representatives of a gene family described among Leptospira (61, 126, 127). Presence of 
sphingomyelinase genes in many of the pathogenic serovars suggests they may be necessary 
for survival of the organism. The presence of multiple related genes within the genome of a 
single organism may have arisen from gene duplication; this duplication may allow 
pathogens to broaden the range of environments in which they survive. 
Sphingomyelinases are a type of phospholipase. Bacterial phospholipases interact 
with the phospholipids of eukaryotic membranes. An example of interactions between 
eukaryotic membranes and bacterial phospholipases can be seen in infections with the 
intracellular pathogen Listeria monocytogenes. Two different phospholipases present in L. 
monocytogenes are believed to act synergistically. One of the phospholipases provides the 
bacteria a means of escape from double-membrane bound vacuoles, allowing for cell-to-cell 
100 
spread, while the second phospholipase is believed to function in escape from the primary 
vacuole encountered on infection (132). Other bacteria possess multiple phospholipases as 
well, but in many of these bacteria the functions of these phospholipases are not well 
characterized (85, 98, 114). Leptospira have recently been reported to enter and survive in 
eukaryotic cells (105), the role of sphingomyelinases or other phospholipases in entry and 
survival within these cells is unknown. Studies using full-length proteins should be 
performed to evaluate the effects of leptospiral sphingomyelinases on different eukaryotic 
cell types. 
Conservation of sequence among isolates of serovar hardjo in sphA may indicate that 
SphA is not subjected to envirormiental pressures or that strict conservation of the sequence 
is required. The presence of some properties of Gram-positive proteins in SphB should 
encourage the use of new expression methods for leptospiral proteins and expand views on 
leptospiral outer membrane structure and protein export. Reliance on Escherichia coli may 
not always provide optimal expression of recombinant leptospiral proteins. 
The significance of the repeated elements in sphB is unclear but warrants further 
investigation. As reviewed by van Belkum et al. (148), short-sequence DNA repeats occur in 
the genome of many different bacteria. These repeated sequences may be dispersed or 
contiguous within the genome. Contiguous repeats vary in composition from monomers of 
polynucleotide repeats to much larger and more complex repeats. Functions are known for 
some of these repeats and unknown for others. Shifts in reading frame may occur with 
changes in the number of repeats and can result in phenotypic variability as is seen with LPS 
biosynthesis in Haemophilus influenzae. Repeated sequence variability within promoter 
regions can result in phase variation due to effects on transcriptional efficacy in H. influenzae 
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and Neisseria meningitidis. N. gonorrhoeae opacity proteins vary because of translational 
reading frame shifts due to changes in numbers of DNA repeats. In Staphylococcus aureus, 
the genes encoding several membrane bound proteins involved in recognizing adhesive 
matrix molecules contain contiguous repetitive DNA. The repeats may function in the 
protein as a stalk, allowing surface exposure of the active domain. Differences in the repeat 
region may result in differential exposure of the proteins active site. This may lead to 
differences in biological activity and sensitivity to the host immune response. In 
Streptococcus pneumoniae a repeated region in PspA may be involved in protein attachment 
to the bacterial cell. Repeats in other organisms have been used for antigenic variation (65, 
87, 101). 
The makeup of the repeated sequences in serovar hardjo RE A type A isolates 
examined consisted of a highly ordered array of a conserved 45 bp repeat. REA type B 
isolates examined, in contrast, contained a single 45 bp element followed by variable 
numbers of a 30 bp repeat. The 30 bp repeat was highly homologous to the 45 bp element, 
but did not include the initial 15 bp of the 45 bp element. Maintenance of the ORF o^sphB 
was observed in both REA types. In addition, the length and conservation of the repeat 
sequence make it unlikely that variability in repeat number functions in immune evasion. 
Therefore, the repeat region may function in the proper orientation or assembly of the 
protein's active site. It is also possible that this region of repeats may function in binding of 
SphB to the bacterial cell or the host cell. The region of the protein encoded for by the repeat 
region is rich in serine, but any role this may play in the function of the repeats is not known. 
Again, until methods to delete or mutate genes in Leptospira become available, evaluation of 
the importance of individual proteins in the pathogenesis of leptospirosis will be difficult. 
102 
Thoughtful experimental design and the use of multiple approaches will be the key to 
successful studies. 
A reproducible and virulent model of infection in hamsters was developed using a 
colony-purified L. borgpetersenii serovar hardjo strain 197. Lesions developed within 5-9 
days following infection with lO*" organisms and included external and internal evidence of 
hemorrhage. Previous reports of hamster virulent serovar hardjo isolates (93, 156) have not 
described development of hemorrhagic lesions, and the isolates used in those studies were not 
colony-purified. The development of this model should have application in the evaluation of 
the efficacy of serovar hardjo vaccines. 
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APPENDIX A—ADDITIONAL FIGURES AND TABLES 
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Figure A. 1: Immunoblot of recombinant AXH3 protein. Recombinant AXH3 protein was 
separated by SDS-PAGE, blotted to Immobilon™-P and reacted with different 
antiserum, followed by secondary antibody (either 1:5,000 horseradish 
peroxidase-Iabeled anti-rabbit IgG or 1:500 horseradish peroxidase-Iabeied 
anti-mouse IgA, IgG, and IgM. Reactions were developed using ECL™ 
detection reagents. The autoradiogram is presented. Lanes represent different 
antisera: Lanel, 1:20,000 rabbit anti—AXH3; Lane 2, 1:10,000 anti-T7 MAb; 
Lane 3, secondary anti-mouse only; Lane 4, 1:10,000 normal mouse. 
Molecular mass markers are indicated to the left of the figure in kDa. 
Figure A.2: Hybridization of ["P] labeled-pHL2-B3 to blot of RT-PCR and PCR products for sphA and sphB shown in Figure 
3.19. In lanes 1-7 primers 34 and 35 were used to detect sphA and in Lanes 9-15 primers 35 and 37 were used to 
detect sphB. Lanes 1 and 9 are positive control PCR reactions using genomic DNA from strain Sponselee and 
primers 34 and 35, and primers 36 and 37 respectively. RT-PCR reactions were performed and are seen in Lanes 
2-7 and Lanes 10-15. The symbol + indicates reverse transcriptase was added to the reaction and - indicates no 
reverse transcriptase was added. Lanes 2, 3,9, and 11, strain Sponselee; Lanes 4, 5,12, and 13, strain 033; Lanes 6, 
7, 14, and 15, strain 197. DNA size markers are listed to the left of the figure. 
Kb 1 2 3 4 5 
1636— 
506 517-
1396-
9 10 11 12 13 14 15 Kb 
o 
o\ 
& 
107 
TABLE A.1. Bovine isolates of L. borgpetersenii examined by hybridization with sphA and 
sphB 
Country of Origin Number examined REA Type 
United States 95 A 
United States 24 B 
Northern Ireland 22 A 
Northern Ireland 1 A* 
Chile 22 A 
Canada 20 A 
Switzerland 5 A 
Israel 3 B** 
Scotland 2 A 
New Zealand 2 A 
Ecuador 1 A 
Portugal 1 A 
Italy 1 A 
Unknown 1 A** 
^Isolated from human. 
**Animal from which isolate was obtained is unknown. 
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APPENDIX B—PROTOCOLS 
109 
Protocols 
Reagents. Triton X-100 and Triton X-l 14 were obtained from Sigma Chemical Co. 
(St. Louis, Mo.). Horseradish peroxidase labeled goat anti-rabbit IgG, alkaline phosphatase 
labeled anti-mouse IgG, IgA, and IgM, alkaline phosphatase labeled anti-rabbit IgG were 
obtained from Kirkegaard and Perry Labs., Inc. (Gaithersburg, Md.). Advantage Tth DNA 
polymerase mix (50x) and lOx Tth buffer were obtained from Clonetech Labs (Palo Alto, 
Calif). En^hance was purchased from Dupont (Boston, Mass.). L-[U-"C] Leucine (305 
mCi/mmol) was obtained from ICN Biomedicals. Inc. (Costa Mesa, Cahf). ECL™ protein 
molecular weight markers were purchased from Amersham Life Sciences (Arlington Heights, 
111.). Formulas for the solutions used in the following protocols are listed in Table B.l. 
TABLE B.l. Solutions used in protocols. 
Protocol Solution Formula 
Genomic DNA Preparation TES 50 mM Tris-base 
5 m.M Sodium EDTA 
25% Sucrose 
CsCl-TESP 2.5 ml IM Tris-HCl. pH 8.0 
0.5 ml 0.5 .M Na EDTA 
0.5 mi 5M NaCl 
0.25 ml PMSF, (10 mg/ml) m 95% Ethanol 
46.25 ml sterile distilled H,0 
63.05 gCsCl 
TE 10 miVI Tris-base, pH 8.0 
1 m.M Na EDTA 
Restriction endonuclease 
digestion and electophoresis 
Tracking dye 0.1% bromphenol blue 
20% Ficoll type 400 in distilled H,0 
TBE. pH 8.2 89 mM Tris-base 
2 mM Na EDTA 
89 mM Boric acid 
Ethidium bromide 0.25 ug/tnl 
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TABLE B.l (continued) 
Capillary blotting Denaturation buffer 1.5 M NaCI 
0.5 M NaOH 
Neutralization buffer 1.5 M NaCI 
0.5 .M Tris-HCU pH 7.2 
0.001 M Na EDTA 
20X SSC 3 M NaCI 
3 M Sodium Citrate 
Recombinant Protein 
Purification 
Guanidinium lysis buffer. pH 7.S 6 M guanidine HCI 
20 mM sodium phosphate 
500 mM NaCI 
Denaturing binding buffer, pH 
7.8 
8 M Urea 
20 mM sodium phosphate 
500 mM NaCI 
Denaturing wash buffer. pH 6.0 8 M Urea 
20 mM sodium phosphate 
500 mM NaCI 
Denaturing wash buffer. pH 5.3 8 M Urea 
20 mM sodium phosphate 
500 mM NaCI 
Denaturing elution buffer. pH 
4.0 
8 M Urea 
20 mM sodium phosphate 
500 mM NaCI 
Dialysis solution 10 mM Tris-HCI. pH 8.0 
0.1% Triton X-100 
Triton X-114 Outer 
Membrane Preparation 
TBS 50 mM Tns-HCl, pH 7.2 
150 mM NaCI 
2% Triton X-114 in TBS 2% Triton X-114 
Supplies. E. coli T7 extract system for circular DNA kit and Access RT-PCR kit 
were purchased from Promega, Inc. (Madison, Wise.), polyallomer Quick-Seal™ centrifuge 
tube (13 X 51 mm; Beckman, Palo Alto, Calif). Hybond™-N and ECL™ detection reagents 
were obtained from Amersham Life Science (Arlington Heights, 111.). Autoradiography film 
was Biomax MR purchased from Eastman Kodak Co. (Rochester, N.Y.). Universal 
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GenomeWalker™ kit and the CLONsep kit for RNA purification were obtained fi"om 
Clonetech Labs (Palo Alto, Calif.). The TA cloning kit, Xpress™ kit, and ProBond™ 
columns were purchased fi-om Invitrogen Corp. (Carlsbad, Calif.). E. coli (XL- Blue) were 
obtained from Stratagene Cloning Systems (La Jolla, Calif.) or Nova Blue (DE3) were 
obtained from Novagen (Madison, Wise.). MPL® -i- TDM -i- CWS Emulsion, (R-730) was 
purchased from RIBl ImmimoChem Research, Inc. (Hamilton, Mont.). TiterMax™ #R-l 
adjuvant was obtained from CytRx®, Corp. (Norcross, Ga.). Gel blot paper was purchased 
from Schleicher & Schuell (Keene, N.H.). Immobilon-P was obtained from Millipore Corp. 
(Burlington, Mass.). PLM-5 medium was purchased from Intergen Corp. (Purchase, N.Y.). 
Geoomic DNA preparation. Procedures used have been previously described. 
Leptospira were grown in PLM-5 at 29°C to log phase, approximately 150 ml of culture was 
centrifuged at 10,000 rpm for 30 min at 4°C in a J2-21 centrifuge using a JA-10 rotor. The 
cell pellet was then suspended in sterile 0.01 M PBS, followed again by centrifugation under 
the same conditions. This pellet then was suspended in 1 ml of PBS, transferred to a 1.5 ml 
polypropylene tube and spun at 15,000 rpm in an Eppendorf table-top centrifuge. The 
resulting pellet was then suspended in 500 TES, and transferred to a polyallomer Quick-
Seal™ centrifuge tube (13 x 51 mm). To this suspension, 130 fA of lysozyme (5 mg/ml in 
TES) was added, mixed gently and held on ice for 15 min. Three ^.\ of proteinase K (20 
mg/ml in sterile distilled H,0) was added to this solution, followed by the addition of 130 lA 
of 0.5 M EDTA and 67 of 10% sarkosyl. The tube was covered with foil and incubated in 
a water bath at 65°C overnight. 
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Approximately 4 ml of freshly prepared CsCl-TESP was added to fill the polyallomer 
tube, which was then sealed and spun at 65, 000 rpm, 4°C, for 4 h using a VTi 65.2 rotor in a 
Beckman L8-80M ultracentriftige. 
The polyallomer tube was pierced with a 16 gauge needle approximately 5 mm from 
the bottom and vented at the top using an 18 gauge needle. The viscous fluid containing the 
DNA was collected from the bottom needle, and dialyzed against TE buffer at 4°C, with 3 
changes during 24 h. 
Restriction endonuclease digestion, capillary transfer, and hybridization. 
Procedures similar to those used in this study have been described (143). Leptospiral 
genomic DNA (2 ^g) was digested using 4 to 5 units of the appropriate restriction enzyme, in 
a total reaction volume of 20 u\. Reaction conditions were those recommended by the 
manufacturer. 
Tracking dye, 5 i^l, was added to the digested DNA. Digestions were then 
electrophoresed for 16 h at 60 V in a 20 x 25 cm gel box using 0.7% agarose gels, buffered in 
Tris borate buffer (TBE). Gels were then stained with ethidium bromide for 1 h and 
photographed under shortwave UV using a Kodak 23A red filter. 
Gels were then processed for capillary blotting as has been described (163-165) and 
according to manufacturer's directions. Briefly, gels were rinsed in distilled H^O. then 
soaked for 1 h with shaking in denaturation buffer. Gels were again rinsed in distilled H;,0, 
followed by soaking for 1 h with shaking in neutralization buffer. The gel was then capillary 
blotted to Hybond™-N, using 20x SSC (123), also according to manufacturer's directions. 
DNA was immobilized on the membrane by UV crosslinking using 120 millijoules. 
Membranes were prehybridized for at least 4 h at 56°C in 6x SSC, 0.1% SDS (v/v), 2.5% 
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nonfat dry milk (w/v). Hybridization with radioactively labeled probes at 56°C was 
performed overnight in the same solution. Washing consisted of one 5 min 6x SSC wash, 
three 5 min 2x SSC washes, and four 15 min 2x SSC washes with 0.1% SDS. Excess wash 
solution was removed from the blots, blots were wrapped in plastic-wrap and exposed to 
Biomax MR at -80°C for varying periods of time. 
PGR, restriction digestion, genome walking and cloning of PGR products. PGR 
reactions were performed in a GeneAmp PGR System 9600 (Perkin-EImer Corp., Norwalk, 
Conn.), using appropriate primer sets and the following reaction conditions. Twenty-five ul 
reactions containing 2.5 lA lOx PGR buffer II (Mg free), 4 (A lOmM dNTP mix, 10 A 25 
mM MgGU, I fA genomic DNA, 11.75 «1 sterile distilled H^O, 2.5 units Taq DNA 
polymerase, and 50 pmol of each of the appropriate primers. Reaction conditions consisted 
of a 30 sec 94'^C denaturation, followed by a 30 sec template/primer annealing step, and a 2 
min 72 °C extension step for a total of 25 cycles. The temperature of the template/primer 
annealing step was set at either 50°G, 55°C, or 6Q^C and was dependent on the Tm of the 
primer pairs used. A fluther extension step of 1 h at 67°C was performed to ensure extension 
and the addition of the A overhang by the polymerase. 
Genome walking was performed using the Universal GenomeWalker™ kit, according 
to manufacturer's instructions. Digestion reactions were prepared with the following 
adjustments to reaction volumes. Each reaction contained 20 u\ genomic DNA, 6 jA 
restriction enzyme, 10 ,^1 restriction enzyme buffer, and 64 A sterile distilled H,0 and was 
incubated overnight at 37°G. The digests were precipitated using ammonium acetate, 
followed by 95% and 70% ethanol washes. The final pellet was suspended in 100 A sterile 
distilled H^O. 
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Ligation of the digested DNA to the kit adaptor was carried out in the following 
reaction mixture: 1.6 u\ adaptor, 1.6 /^l 5x ligation buffer, and 0.5 /il T4 DNA ligase. The 
reaction was incubated overnight at 16°C, followed by 5 min at 70°C to linearize any 
unligated products. Seventy-two of sterile distilled H,0 was then added to this mix, which 
was then used with the adaptor primer, AP-1, and primers from known sequence to amplify 
DNA sequence beyond that already described. 
PCR reactions were also performed in the 9600 and the reaction mixes consisted of 
37.8 sterile distilled H^O, 5 fA lOX Tth PCR reaction buffer, I (A dNTPs (10 mM each), 
2.2 Ail Mg(OAc)2 (25 mM), 1 ^J.\ API (10 mM), 1 lA of the ligated genomic digest, 1 iA of 
known primer (50pM), and 1 lA Advantage Tth DNA polymerase mix (50x). The PCR 
conditions used for genome walking were as follows: 2 sec 94°C denaturing, 7.5 min 72°C 
template/primer annealing and 0 sec 72°C extension for a total of 7 cycles, then 2 sec 94""C 
denaturing, 7.5 min 67 °C template/primer annealing and 0 sec 72 °C extension for 32 cycles. 
A funher extension of 1 h at 67°C was also performed to ensure placement of the A overhang 
by the pohTnerase. 
Cloning of PCR and genome walking PCR product into pCR2.I was performed using 
the TA Cloning kit, according to manufacturer's directions. Fresh PCR product was ligated 
into pCR2.1 by mixing 1 ^A PCR product, 5 ^A sterile distilled H,0, 2 lA pCR2.1 vector, 1 u\ 
lOx ligation buffer and 1 T4 DNA ligase, incubating overnight at 14°C, and then heating 
to 70°C for 5 min to linearize any unligated products. 
Transformation of One Shof"^* DH5a E. coli, included with the kit, using I to 2 /^1 of 
the ligation reaction was followed by selection for growth of white colonies overnight on 
DYT plates containing kanamycin (50 /zg/ml.) and 40 ^A of a 40 mg/ml solution of 5-bromo-
115 
4-chIoro-3-indolyI P-D-galactopyranoside spread on previously made plates and allowed to 
dry for 15 min. 
RNA preparation. The procedure used is a modification of that suggested by the 
manufacturer. Using cultures growing in log phase with cell density of 10® to 10' cells/ml, a 
total of 60 ml of culture was spun in two appropriately treated centrifuge tubes to avoid 
RNase contamination. Cells were spun for 15 min, 15,000 rpm at 4°C using a JA-17 rotor in 
a J2-21 centrifuge. Supernatant was poured off and cells suspended in sterile 0.0 IM PBS, 
with the cell suspension on ice. The spin was repeated and supernatant decanted. Cells were 
suspended and the cell pellets combined with suspension in 3 ml CLONsep A. The 
suspension was transferred to a new polypropylene tube and held at room temperature for 5 
min. 
This solution was centrifliged at 6,500 rpm using a JS-7.5 rotor for 15 min at 4°C. 
Supernatant was removed and 2 ml CLONsep B was used to suspend the cell pellet. 
Suspension was held at room temperature for 5 min, followed by the addition of 0.6 ml 
chloroform, with vigorous shaking for 10 sec. The suspension was cooled on ice for 15 min 
and then spun again as above for 15 min. The upper aqueous phase contained the RNA and 
was transferred to a new polypropylene tube, being careful to avoid contamination with the 
lower phase. Sample volume was estimated and 95% ethanol dropwise, while mixing. The 
solution was stored at -20°C for I h to precipitate the RNA, then centrifuged again for 15 
min in the JS-7.5 rotor, 6,500 rpm for 15 min at 4°C. Supernatant was removed and the 
pellet was air dried for 5 min. The pellet was resuspended in 1 ml or less of DEPC treated 
distilled H,0. RNA solutions were stored until use at -70°C. 
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Reverse transcriptase-PCR (RT-PCR). The protocol recommended with the 
Access RT-PCR kit was modified to eliminate interfering DNA present within the RNA 
preparations (37). Two stock solutions were prepared, the first containing target RNA, 
sufficient RNase-firee DNase to degrade any DNA present in the preparation, nuclease-fi-ee 
HjO, dNTPs, and AMV/^ reaction buffer. This solution was incubated at 37°C for 30 min, 
heated to 95°C for 5 min, and then taken to 22°C for 10 min before addition of the second 
stock solution. 
The second stock solution contained the remainder of the reaction components, 
including Tfl DNA polymerase, MgSO^, primers and nuclease-free H^O. A control for the 
presence of contaminating DNA was provided by either including or withholding AMV 
reverse transcriptase from the second portion of the reaction. Contaminating DNA would 
yield a false positive product, which would be detected in the absence of AMV reverse 
transcriptase. Positive control reactions were provided by using genomic DNA as target for 
the RT-PCR primers in a routine PCR reaction. PCR and RT-PCR were performed in a 
GeneAmp PCR System 9600. An initial incubation at 48°C for 45 min was followed by 
heating to 94°C for 2 min. The conditions for PCR were as follows, a 30 sec 94°C 
denaturation step, a 1 min 60°C template/primer annealing step, and a 2 min 68°C extension 
step, repeated for 40 cycles. 
PCR and RT-PCR products were electrophoresed in a 1% agarose gel in TBE buffer, 
stained with ethidium bromide and photographed, blotted and hybridized as described above. 
Expression and purification of recombinant protein AXH3. E. coli (XL-1 Blue) 
or Nova Blue(DE3) containing the expression plasmid, pAXH3, were processed according to 
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manufacturer's directions for batch purification under denaturing conditions using the 
Xpress™ kit for protein purification. 
Briefly, cells were grown in 50ml of DYT medium containing ampicillin, 100 ^ug/ml 
at 37°C with shaking until reaching an absorbance of 0.3 to 0.4 A^. Isopropyl P-D-thio-
galactopyranoside was added to a final concentration of 1 mM, and Ml3 phage was added to 
a multiplicity of infection of 5 to 10 pfli/cell for the XL-1 Blue cells. Cells were grown 
overnight and harvested by centrifiigation at 5,000 rpm for 5 min at 4°C using a JA-17 rotor 
in a J2-21 centrifuge. 
The cell pellet was suspended in 10ml of guanidinium lysis buffer, equilibrated to 
37°C. The suspension was rocked for 5 to 10 min at room temperatm-e to assure cell lysis, 
and then sonicated with three 5 sec pulses on ice to shear DNA and RNA. Insoluble debris 
was removed by centrifiigation at 4,750 rpm for 15 min at 4°C using a JA-17 rotor in a J2-21 
centrifuge. The lysate was then transferred to a new tube and held on ice until use. 
ProBond"'"'^' columns were prepared by washing the resin twice with 7 ml sterile 
distilled H^O, followed by three washes using 7 ml denaturing binding buffer. The final 
wash was removed, and the cell lysate was bound to the resin by rocking for 10 min at room 
temperature. The lysate was split into two 5 ml aliquots, aspirating the first after binding for 
10 min, and repeating with the second aliquot. 
The column was then washed twice with 4 ml of denaturing binding buffer, followed 
by two washes with 4ml denaturing wash buffer (pH 6.0), two washes with 4ml denaturing 
wash buffer (pH 5.3), and finally eluted with 5 ml denaturing elution buffer. This solution 
was dialyzed at 4°C overnight. The resulting solution was concentrated using a centricon 10 
obtained firom Amicon, Inc. (Beverly, Mass.). 
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Polyclonal and monoclonal antiserum preparation. Polyclonal antiserum to 
purified protein AXH3 was prepared by suspending AXH3 in MPL' + TDM + CWS 
Emulsion ( R-730) according to manufacturer's directions to deliver 0.2 mg protein per 
injection. A 6-month-oId, female rabbit was checked for presence of agglutinating antibodies 
to Leptospira by the MAT. The rabbit was immimized four times with repeated injections 5, 
9, and 13 weeks after the first injection. The rabbit was euthanized 16 weeks after the first 
immunization and serum was harvested. 
The polyclonal antiserum was checked for reactivity by immunoblot to the dialyzed 
and concentrated protein preparation used for immunization. Secondary antibody was 
horseradish peroxidase labeled goat anti-rabbit IgG. 
Monoclonal antibodies were prepared by giving purified AXH3 protein suspended in 
TiterMax"'"'^' #R-1 adjuvant. The antigen-adjuvant emulsion, 0.2 ml, containing 50 yug soluble 
protein, was given by intraperitoneal injection to 6- to 7-week-old BALB/C mice. Four 
weeks following the first injection a second injection was also given by the intraperitoneal 
route. The mice were restimulated by giving one or two intravenous injections with 5 to 10 
ag protein via the tail vein. Restimulation was performed 2 to 3 days prior to spleen harvest 
and fusion. Hybridoma preparation and culture was carried out by Karen S. Halloum. NADC 
Biological Sciences Laboratory Technician, according to described procedures (161). 
Monoclonal antibodies were checked for reactivity using the Easy-Titer™ ELIFA 
system fi'om Pierce (Rockford, 111.). Protein AXH3, 200 lA of .004 mg/ml solution, was 
pulled through the wells onto a nitrocellulose membrane. Individual wells were blocked by 
pulling 200 Ail of 3% bovine serum albumin through the membrane. This was followed by 
adding 200 of monoclonal antibody and pulling it through the membrane. Secondary 
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antibody, 200 ul of 1:5,000 alkaline phosphatase conjugated anti-mouse IgG, IgA, and IgM, 
was then pulled through the membrane, followed by three washes of 200 each of 0.0IM 
PBS. This was then followed by addition and pulling through of 200 of BCEP/NBT 
phosphatase substrate. Negative controls lacking antigen, primary, or secondary antibody 
were performed as was a positive control using the polyclonal rabbit serum and alkaline 
phosphatase labeled anti-rabbit IgG. 
In vitro translation and fluorography. Plasmids purified by CsCl centrifligation 
(10) were used in the E. coli T7 extract system for circular DNA kit. DNA template <4 
was added to: 5 lA of amino acid mixture minus leucine, 20 u\ S30 premix without amino 
acids, 5 u\ L-[U-''*C] Leucine (305 mCi/mmol) and nuclease-free water sufficient to bring the 
total reaction volume to 50 tA. The final component added to the reaction mix was 15 /^1 of 
T7 S30 extract for circular DNA. 
This mix was then incubated at 37"C for 1 h and stopped by placing in an ice bath for 
5 min. A negative control reaction containing no DNA was also included among the 
reactions perforaied. Reaction products were stored until use at -20'C. 
Ten u\ of the resulting product was run on an SDS-PAGE gel followed by staining for 
2 h in 0.125% coomassie brilliant blue R-250 in 50% methanol, 10% glacial acetic acid, with 
overnight destaining in 5% methanol, 7.5% glacial acetic acid in distilled H,0. The gel was 
soaked twice for 10 min each in 50% methanol, 30% acetic acid with agitation. This was 
followed by soaking for 2 h in 3 gel volumes of En^hance, again with agitation. The gel was 
then agitated in 6 gel volumes of distilled H,0 for 1 h. The gel was mounted and dried on 
gel blot paper and exposed to Biomax MR for 7 days at -70°C. 
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Triton X-114 outer membrane preparation. The procedure employed is similar to 
that already described (167). Briefly, 100 ml of mid-log to late-log phase cells were harvested 
by centrifugation at 16,000 rpm at 4°C using a JA-17 rotor in a J2-21 centrifuge. Cell pellets 
were suspended twice in 10 ml cold TBS and centrifuged. This cell pellet was then 
suspended in 2 ml ice cold 2% triton X-114 in TBS. This suspension was held on ice for 20 
min with occasional vortexing. Protoplasmic cylinders were removed by centrifugation at 
10,000 rpm for 15 min at 4°C. Supematant was removed to a clean tube and centrifugation 
was repeated. 
SDS-PAGE and immunoblotting. Protein analysis and immunoblotting and was 
performed by SDS-PAGE electrophoresis using a tris-tricine-buffered system (124). 
Resolving gels were prepared by first mixing 7.5 ml 40% T, 2.6% C acrylamide-bis with 10 
ml gel buffer, (3M Tris-base, pH 8.45), 175 ul 10% SDS, 4 ml glycerol, and 8.5 mi sterile 
distilled H^O. When mixed, 30 fA TEMED, and 150 uX freshly prepared 10% ammonium 
persulfate were added and mixed thoroughly. This mixture was poured immediately and 
allowed to polymerize for 1 to 2 h. The stacking gel was prepared by mixing 1.5 ml of the 
acrylamide-bis, 3.1 ml gel buffer, 80 //I 10% SDS and 8.28 ml of sterile distilled H,0. 
When mixed 12.5 ul TEMED and 125 freshly prepared 10% ammonium persulfate were 
added and mixed thoroughly. This was then poured on top of the resolving gel. 
Polymerization was allowed to occur for 2 to 6 h. Gels were run overnight at 15 mA and 70 
to 100 mA for 3 to 5 h. Molecular weight standards used were either ECL protein molecular 
weight markers or protein molecular weight standards (broad range). Samples were denatured 
in sample buffer (4% SDS, 12% glycerol, 50mM Tris-base, pH 6.8,2% 2-mercaptoethanol, 
and 0.005% bromphenol blue). 
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Blotting of gels to Immobilon-P was accomplished using a Multiphor 11 NovaBlot 
unit Pharmacia Biotech, Inc. (Piscataway, N.J.). Semi-dry transfer using transfer buffer, was 
performed at 200 mA for 1.5 to 2 h. 
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